var title_f17_33_17936="Fixation in malrotation";
var content_f17_33_17936=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Shortened mesenteric attachment",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 369px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mesenteric fixation in malrotation. Most anomalies of rotation result in an abnormally narrow mesenteric base (demonstrated by the red line). The suspension of the midgut on this narrow vascular pedical increases the risk of volvulus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17936=[""].join("\n");
var outline_f17_33_17936=null;
var title_f17_33_17937="Laryngeal inlet photograph";
var content_f17_33_17937=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F56601&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F56601&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Laryngeal inlet photograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 444px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The epiglottis and glottis of an infant; note the apposition of the vocal cords from laryngospasm in the right-hand image.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Orebaugh SL. The pediatric airway. In: Atlas of Airway Management: Techniques and Tools, Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17937=[""].join("\n");
var outline_f17_33_17937=null;
var title_f17_33_17938="Dissection of greater omentum";
var content_f17_33_17938=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F53153&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F53153&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 550px\">",
"   <div class=\"ttl\">",
"    Dissection of greater omentum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 530px; height: 457px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The gastrectomy is initiated by taking down the greater omentum and preserving it with the transverse colon and mesocolon inferiorly.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17938=[""].join("\n");
var outline_f17_33_17938=null;
var title_f17_33_17939="Trifluridine: Drug information";
var content_f17_33_17939=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Trifluridine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?0/5/94?source=see_link\">",
"    see \"Trifluridine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/47/43762?source=see_link\">",
"    see \"Trifluridine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F231119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Viroptic&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F231120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Sandoz-Trifluridine;",
"     </li>",
"     <li>",
"      Viroptic&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F231145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiviral Agent, Ophthalmic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F231121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Herpes keratoconjunctivitis, keratitis:",
"     </b>",
"     Ophthalmic: Instill 1 drop into affected eye every 2 hours while awake, to a maximum of 9 drops daily, until re-epithelialization of corneal ulcer occurs; then use 1 drop every 4 hours while awake for another 7 days (minimum daily dosage of 5 drops is recommended). Do",
"     <b>",
"      not",
"     </b>",
"     exceed 21 days of treatment; if improvement has not taken place in 7-14 days, consider another form of therapy",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F15669362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/47/43762?source=see_link\">",
"      see \"Trifluridine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;6 years and Adolescents: Ophthalmic: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F231122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F231107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic [drops]: 1% (7.5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Viroptic&reg;: 1% (7.5 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F231093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F15669363\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For ophthalmic use only; avoid touching tip of applicator to eye or other surfaces. Wash hands before and after instillation.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F231109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of primary keratoconjunctivitis and recurrent epithelial keratitis caused by herpes simplex virus types I and II",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F231151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Viroptic&reg; may be confused with Timoptic&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F231143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Ocular: Burning or stinging (5%), palpebral edema (3%), epithelial keratopathy, hyperemia, hypersensitivity reactions, irritation, keratitis sicca, ocular pressure increased, stromal edema, superficial punctate keratopathy",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F231112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to trifluridine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F231097\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Irritation: Mild local irritation of conjunctival and cornea may occur when instilled but usually transient effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F231101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F231103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13823810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects were not observed during animal reproduction studies of the ophthalmic solution.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F231124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13823811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The amount of trifluridine available systemically following topical application of the ophthalmic drops is negligible.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F231113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Trifluridine Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (7.5 mL): $178.28",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Viroptic Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1% (7.5 mL): $203.27",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bephen (HK, LU);",
"     </li>",
"     <li>",
"      Ocufridine (KP);",
"     </li>",
"     <li>",
"      TFT (BE, NL);",
"     </li>",
"     <li>",
"      TFT Ophtiole (PH, TW);",
"     </li>",
"     <li>",
"      Tri Fluoro Timidina Poen (AR);",
"     </li>",
"     <li>",
"      Triflumann (DE, LU);",
"     </li>",
"     <li>",
"      Trifluridin Thilo (AT);",
"     </li>",
"     <li>",
"      Triherpine (CH, GR, HU, IT, PL);",
"     </li>",
"     <li>",
"      Trivirina (CO);",
"     </li>",
"     <li>",
"      Viridin (PT);",
"     </li>",
"     <li>",
"      Viromidin (ES);",
"     </li>",
"     <li>",
"      Virophta (FR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F231096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Interferes with viral replication by inhibiting thymidylate synthetase and incorporating into viral DNA in place of thymidine.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F231111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Ophthalmic: Systemic absorption negligible, corneal penetration adequate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half life elimination: 12 minutes",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Carmine AA, Brogden RN, Heel TM, et al, \"Trifluridine: A Review of Its Antiviral Activity and Therapeutic Use in the Topical Treatment of Viral Eye Infections,\"",
"      <i>",
"       Drugs",
"      </i>",
"      , 1982, 23(5):329-353.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/33/17939/abstract-text/6284470/pubmed\" id=\"6284470\" target=\"_blank\">",
"        6284470",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10021 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-FB51BAF4EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17939=[""].join("\n");
var outline_f17_33_17939=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231119\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231120\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231145\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231121\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15669362\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231122\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231107\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231093\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15669363\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231109\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231151\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231143\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231112\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231097\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300175\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231101\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231103\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13823810\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231124\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13823811\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231113\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038851\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231096\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231111\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10021\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10021|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?0/5/94?source=related_link\">",
"      Trifluridine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/47/43762?source=related_link\">",
"      Trifluridine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_33_17940="Zileuton: Drug information";
var content_f17_33_17940=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Zileuton: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?14/1/14357?source=see_link\">",
"    see \"Zileuton: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/308?source=see_link\">",
"    see \"Zileuton: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F235353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Zyflo CR&reg;;",
"     </li>",
"     <li>",
"      Zyflo&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F235373\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      5-Lipoxygenase Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F235355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Asthma:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Immediate release: 600 mg 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Extended release: 1200 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F235366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/308?source=see_link\">",
"      see \"Zileuton: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Asthma:",
"     </b>",
"     Oral: Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F235356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F235357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary in renal impairment or with hemodialysis.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F235358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contraindicated with hepatic im[airment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F235333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zyflo&reg;: 600 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zyflo CR&reg;: 600 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F235319\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F235337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immediate release: Administer without regard to meals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Extended release:  Do not crush, cut, or chew tablet; administer within 1 hour after morning and evening meals.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F235336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prophylaxis and chronic treatment of asthma",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F235371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Central nervous system: Headache (23% to 25%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Chest pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Pain (8%), dizziness, fever, insomnia, malaise, nervousness, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Dyspepsia (8%), diarrhea (5%), nausea (5% to 6%), abdominal pain (5%), constipation, flatulence, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection, vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Leukopenia (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: ALT increased (&ge;3 x ULN: 2% to 5%), hepatotoxicity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia (7%), weakness (4%), arthralgia, hypertonia, neck pain/rigidity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Conjunctivitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Upper respiratory tract infection (9%), sinusitis (7%), pharyngolaryngeal pain (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity reactions, lymphadenopathy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Behavior/mood changes, hepatitis, hyperbilirubinemia, jaundice, liver failure, suicidality, suicide",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F235340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to zileuton or any component of the formulation; active liver disease or transaminase elevations &ge;3 times ULN",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F235323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatotoxicity:  There have been reports of hepatic adverse effects (elevated transaminase levels); serum ALT should be monitored. Females &gt;65 years and patients with pre-existing elevated transaminases may be at greater risk. Discontinue therapy and follow transaminases until normal if patients develop clinical signs/symptoms of liver dysfunction or with transaminase levels &gt;5 times ULN; use caution with history of liver disease and/or in those patients who consume substantial quantities of ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuropsychiatric events: Postmarketing reports of behavioral changes and sleep disorders have been noted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Females &gt;65 years of age may be at increased risk for ALT elevations. Pharmacokinetics were similar in older adults (&ge;65 years) compared to younger adults.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Due to the risk of hepatotoxicity, the manufacturer does not recommend use of zileuton in children &lt;12 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Reversal of bronchospasm: Not indicated for the reversal of bronchospasm in acute asthma attacks, including status asthmaticus; therapy may be continued during acute asthma exacerbations.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F235367\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2C9 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F235328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: Zileuton may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propranolol: Zileuton may increase the serum concentration of Propranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline: Zileuton may increase the serum concentration of Theophylline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Warfarin: Zileuton may increase the serum concentration of Warfarin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F235350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (may increase CNS depression; may increase risk of hepatic toxicity).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Zyflo CR&reg;: Improved absorption when administered with food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease zileuton levels.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F235329\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F235341\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were observed in animal reproduction studies. If a leukotriene modifier is needed during pregnancy, other agents are preferred (ACOG, 2008).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F235362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F235342\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if zileuton is excreted into breast milk. Due to the potential tumorigenicity of zileuton in animal studies, the manufacturer does not recommend breast-feeding.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F1674946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immediate release: Take without regard to meals.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Extended release:  Take with food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F2524729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, 12-hour",
"     </b>",
"     (Zyflo CR Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600 mg (120): $1799.98",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Zyflo Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600 mg (120): $1799.98",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F235331\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hepatic transaminases (prior  to initiation  and during therapy), specifically monitor serum ALT (prior to initiation, once-a-month for the first 3 months, every 2-3 months for the remainder of the first year, and periodically thereafter for patients receiving long-term therapy)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F235322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Specific 5-lipoxygenase inhibitor which inhibits leukotriene formation.  Leukotrienes augment neutrophil and eosinophil migration, neutrophil and monocyte aggregation, leukocyte adhesion, increased capillary permeability, and smooth muscle contraction (which contribute to inflammation, edema, mucous secretion, and bronchoconstriction in the airway of the asthmatic.)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F235339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: 1.2 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 93%, primarily albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic and gastrointestinal; zileuton and N-dehydroxylated metabolite can be metabolized by CYP1A2, 2C9, and 3A4",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: Immediate release: 1.7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~95% primarily as metabolites); feces (~2%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Asthma In Pregnancy,&rdquo; ACOG Practice Bulletin No. 90. American College of Obstetricians and Gynecologists,",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2008, 111(2 Pt 1):457-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/33/17940/abstract-text/18238988/pubmed\" id=\"18238988\" target=\"_blank\">",
"        18238988",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"The Use of Newer Asthma and Allergy Medications During Pregnancy, The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI),\"",
"      <i>",
"       Ann Allergy Asthma Immunol",
"      </i>",
"      , 2000, 84(5):475-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/33/17940/abstract-text/10830999/pubmed\" id=\"10830999\" target=\"_blank\">",
"        10830999",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10054 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-239B17CE44-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17940=[""].join("\n");
var outline_f17_33_17940=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235353\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235373\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235355\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235366\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235356\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235357\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235358\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235333\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235319\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235337\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235336\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235371\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235340\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235323\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235367\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235328\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235350\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235329\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235341\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235362\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235342\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1674946\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2524729\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235331\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235322\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F235339\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10054\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10054|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?14/1/14357?source=related_link\">",
"      Zileuton: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/308?source=related_link\">",
"      Zileuton: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_33_17941="Livedo reticularis - lower extremities";
var content_f17_33_17941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F79545%7EDERM%2F61842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F79545%7EDERM%2F61842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Livedo reticularis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDy8dyKTOQcdabnk84NNZiq8c5rjsegCklupqeNygz61Egx16VMq7gAozSYyeJwzgEVdC9D/Kq0EOzk+lW0RmwOgHvSNBfL3d+TU0VoQOQT7063g+bdk5q7FFkjLfSkMhSNkIyelWPlIJB3VZWNcjknvxStDzlcH8aVwEWMPGDggd8U0kbc9MenepInYkox5qwiJt2uO3pxSGirEOmz8VbjNaESDAB+Unv1FVZI9rZGMDnIqZSynKH5SOfQ0wLqA7PmA9s85/wp4yRgdB3/APrU23kDYDHjpkipgnzZQcHtSAR0ZQpIAz0P+FLsAGSu4detJIz42pjgcD3qSBt6g7cgYyO4oCxVkALtgDPv3FRsuTwPmHSpztjkYjoTmkkGJARgDFA0Z82Y2bI4IqN2+XJOeKuzDMbZGT0rPYccjnoaYzM1Nv3RYH+H865K7kPnkKPnY8e1dTrDbYSF4rJ0izFxfh3GQOSK68NDmZw4qpyRKEPhtGPmSFmlbktjnNWm0meJcJKWUf3xXWpAOMc+1HkLnacgetdvIn0POVVrqcTZyPDdiOUbZBwR2I9a19NUtgAcbzU2v6cpjSeJTuQ9faodFbO7PrXJXp8up34Wrz6M66ybAGTzjFX0IweOevWsewbeVA5OelbvljYTjaT1riasegQqplcNgjaMEZ4q75oVEj9RkVWt2yCqghs4qwEO0FckCpAjTD9VHrmreFEax9hg1FGiqhJOQfSnncu3byScfhSAkAViQACAPyqGO2DOXZiArZwO/tVl5CvCIMscZqHeF2qgJI5b60APZFXcTyp9BUUuCQcgRgVMm5l+Y7Qew70k6hEONuex7ZoFczZ2VwWHyqOoPFU55gw/dj5egPrVm4O/A6qvJzx+NRsiKcsM5HSjYaMtmIk9h0yKR1MnG7aKs3MYY5zgDtVZYy4y+5cd/WmIZJbpsJ7+grPliAf5TkevpWrI8ajbwSehFUH3hiE59x1pq4rGfcx7ecflVCaNT91frzxWvJE5z+7GKzbiJ0UkL0qhGZcx9vvLj8qxbmPLEAVvyhs8ng+1Z95ECM8Z+lUmZtGCeAVPWp9HTdcycdFpk4wxyM1a0THnyDA5TP610U9WctbSLNzT1AmwRnPpWt5PPTrWXCAjK1dDGgaNTzjHc11pHA2UjEB0HPTNMMIC9AR15q+0Qzjkg96Z5JLYIGKfKLmOUEnJ9TSxjcxySOajj5GT19KnQYG4+leaz2EP9frVi2IHaq+BipIwQc9/ftUjRoggDjg9etTIOpxzjk1SjB+9V23JJCkA0MtFmLIYcE1fiGRgAZ9xUKIFGeD7+lWYnOQFOO3rUlpE8EWDtbqanEfzbSPqabECsoLr077asSOEAOAwPtUjsR/ZMY2cKeeelDKwGNv0OelThnK8AkejDNIySohJ+6e2OtA7FY7j95cHH50kMpDhWGM96csjOu0AAjjHr+NMkBKjGR6A9qBWL0TheGXI7EDp9auW53E4OXHr3rn0u3Q8/QkVoW04kUMhwV6jvTsI2HjXbuCnceSKYwVsMh2k0QylxxgYHT/PanCMtuxjnk0g3GyIsqqRyR81V5lyflxnFWjH827pmopv9Ypxkd8dqBpFB5OfXNU5GBZgOnpU1wNjnnoc1RuTtlZ15z0qhMyNZOYgPU4xV3w1aHy5JMcn5Qapalh5VUdzXX6BZCPTYiP4uTxzXpYWPu3Z5OOn7yRAsDAcqc04QllAK/OT0FbBgUkc4pBDuHT9K6rHn8xg3Vl5tvKhTBI6CuTskNveMjcZ/pXphtycYODXFeJrE2WoeYoyh5z9ayrR5oM6MNV5aiLOnHEgbJGD09a6CR84AzzXMabIfMGPzroIsmMksMkZryZI9+LL1mAnzEHB4HNWiuCF/AD1qlbgEJvJGBxV0SFypGcDg1mxjxtAUEYz2qJ1JYsOD6U+Rly3BLZ71XmVumfx9KQ9y1EAEGVzj1pfKzJnuOmBinwRFUCj5jx17U+Uhjxxnj3NMRGwAQnODwP/AK1Zl5PltqgBc4H+NXrtgqkA4UcCsmeUAHJOf1HtRYQ1mVW+XHPPPP4mq802HDMSSaWI7sucEtUi26uSzAHHT/69Ayom+RtwA69KJ4zuwVPHAxVhvlZVPQ+nWjzSQwYbcdMHPHrSAy/L2NtKnJ75pqpFBkqDjvzk5qzOFLkqC31qHymJI71QiKZA/wA6ZyBnA6VnTEsSFGG71oSIqkZ+U+oPFVZxtfgdaaEzJukfacpz6isi5LH5XUr6Z5rp5ELdsfU1m3kACldi5HIxVpktHIXsZAyBTtFbGoRZ6PlavXsJUHjIrLi/cXUTdg4P61vTepy1leLOuVNp+lathKp+Vj+FZ4GfxpUJSQH07V6CPKeqOiEQ2AY4qMxkZ6cUyyuQ6gAjNXMAcsOKpK5k5M84h5wPWrYI59hVSH5RVleg/wA5rypLU91PQepy2CMmpol3HPYdaiUY5J9qnRlA5/CoLRct1JHtWnHAAoYmqNqTkYBz6mryscj64461LNC1CuAp/SrUWAxJABHpVZZEAAG7ngkCpSxOQoyQOc8VJoW1G85Rfm7YGau26yEESBfpmobJx6Kp/M1bkkA+6AeeCRmkwHAgALj3zmlb7u5iOvUdKajFwDgbe2DUwVU42rt9RxU2GUbmAEbiT7Ec5+lUQrg/NyD3rXnTC/uzx6+tU1UYI4IHXtj6VSEyk8QORxzTId0B3A/71WrlcKfJwTjoeM+1VFcMhG0qcdD1z6GmQbVrMHHycnA+b+lXoWwDkcjkc1y9vMY3BViAa3rCbz1YEAMpxn19xSKRelDSJlR3xzVZjnv1/SrC7lUkg8deaqXICZCnkc8UIZm36gN754rOugFXrx29jWjctukAxkDism9b5Dg/MM1pFESK1rH9pv1A5HAx9a9GgtQkSKPl2jHWuM8H2vnXkbHgZLc/pXoKoSSpQYPevXpR5YJHz+Jnz1GyFYj3OfSmvCVxj9KtAd1Iz6HmpliwACcDrt7mtDAobPlBYc4xWJ4rsVuNPEgGSg/IV05iwQMHmoLi1MkLxMMBhg0g2d0eW6WxV8EnIO011Fq6lMgc9AD61zV5C1lqrqeMnt6itnTnzlc5Y815VeHLJo+gw9TngpG5bGLy2yO35U6NvLO3JweB64qtFhpSB93H5Vehiy24jkVzs6rk6NtBIPzdPrToB50oHYetVsDcCvzA9s8irUfyK2OCeB7VIFxYlYEdAOp9Kq3DMBnOO/09BU8RKxZkOP4j/wDXqpNJ8zMeNvJzzzSJM+6lOQGzuHTNZnzSTHJ6c/WrFwzNISxySO/aoowxOAuCe9UBJHHlRjgDn61YbAXqAMdcVEi7Tzk9896jlcSuOcRjuTU2uyhzFSTty3TB9KjljwoOMZ796nQoqbnHIPGajkddu8t8x6A0dQIEgAKtGM+ufWo7ocHcvuCKljlcv8wP4dKbJLuO0jdj15xTHYz1hDA8nGentUc6hD8igKfXrVmRwr4VcD1NRyzLJ8rcnHQUwsUpQjKQwCkd81QlgVxjGTnvV+WFnYlCVHY9arlJGcqxwQOtUiWjAv7TaWUqfqDWBfWxT5l5ArsrmCQjk4UVl3tmQhON3tVqRlKN1YnsZfPs4JM8lMH6jinkc9qytKm+z3Bt5eEc5UHs3p+NbDnHTPNenTkpxueLWg6cmmEE5jfA4rcs7remCQxx3rm3Jz15qSGdom9q2V0YtXMQqUkdG4w2KnQk49ulSatEIr0lR8rgMP61W3HHHJrzqkbOx61KXNFMsw8sc9KsRJuBPaqsIO3joeta0MY2Lt9OnWud6HREtWMfdhkdhV/aeG2ggHr6Uy1G4KCPmx0q4sBblgcDj1qLmqRFF+9YKvX6dKuW1thxuKd/mNEEO0E4ZuM5HAqSMFWGcYJ6ChsuxciCAYIyD3UcZqSZI9nznafrSWzqWAA4Hr1qy0QlY79gHr1qBleCVAQqN0OCc8CrfmD+Ig+wPSsy5gdZDsCH14PSpreRX2o25vagB8pONqjBPOCKrPbyZJXO0enBH+NXRCGZtqn/AD1qRiwUAcjFMDFYsCAfnC9iKZOimPep5HNas1usoyv3gPxFY1xG6ORk7h2PRqaJZXLj5SCcda1tLuRnYT9D7ViuoVcLwOlLaymOZW99p7UEHbicNGWJ+bt71n3IKoQQfm5FNs5Q42ghgOn0qWX51OTyBjmlsWmYzuScMMEVl3+djH3x9a0L/CFQM46fWs3/AF1xFHztzkn6V0Uo3kjCtPli2dh4LsgscjsMAALmupQFX45H86z/AA5B5OmoR0kySD/OtNT8rKwBXqDjtXrs+dvfUCAGGFx3qRAC5BOOc8D+dRn5hktk9s9alt/ukn5gRjnmkA5kBOCMg9M0xosAjHPfntUhA3DAB4+7T9ilh1Bx1FILHn3jnT9rLdIvJ5zjuKxbC4XCuD0Fel67Y/bNOljxmQDcAfUeleTlTbXMkQBAzkew9K58TC65j0MDUs+Q6ezlZgpx8vc+grXgIkOFPFYWnShokUcZ4/Gty1JULjHQ815k0eunoWYkG9hnGDwfSr0cYYkMMDPf0FUYzu+bGATn6irTy7VYAndjH0qB3C5dY4S7HKDH41itcAwSPn/PU0/WLo/Z1XJwflrFDsygNgen09aEhNjwzyvgcZ64q1CnzHI6VWtyVBYDAPY96vQ4VMdx29TTYIa43AgttTqR601IfNcZyq8YAqcKXwCMqD+dTxxfNgZXHU0rloryQ4YlGPPGfWqTQBO+5/UnODWnKu8eWOM8N6/SmNAqrlCOPXtQUkVrW1kx87Bj3GagvIQp2oeSex/nVyMliwyAe/PFO8hZm4AI9fSlfUZjSRdBICSR1A4qstq6PuGcddp5xXSSRRH74yezAdPxqtcQM4ZgAT254qrhYzViLKNuc44B5qvPb7eWwDjHI6VYkkeJwo2AZxjHT6VG+51bMm4dlPBos7iaKckalCrFcHpisi4iB3I2M44J71rT2swQyLuK9yeay75XPzE4b6YqkQ0YOpW3GTww7ipbK7NxDhz+9Tg57+9TyuXyrdRWRIfs10JRwvRx6iumhUcJWOLE0ueN1uanX6U1yegNOLDgrgqeR7008mvSueQT69FmOKUdjj86xm4bnOa6XVED2UuOSPm/KuaPXB+tcteNmduFl7ti7aDlAPXityyjPJABJ71kWUfAY9fSujsocqoUbm6kHp+NcMz0YIuWkZdgVyM8Z6mtMQhUwwAHvyTSWURVT0zildnyTuyD0Hc/SsXqbpDsq3GGJHQDgVZhgJ6KPoOopbGzJLNOQCMYA/oP8a0raCIP8yKxx0ySfx7UN2NCilkyP8oJJ4BBz/8AqpJfP2hQWUL2Q1pSvGrFUZlzxsjIqtLG8g/1ZjA/iLcUk7gU4lHJc/8AfWcmrP2dGBIBJXvg80zyHVhlQy56jI/GrliGdmTMjY6nPShg0V4YdnBYj35zStgKRkZPY8VqGADl8nHXnqPWqVxEjSDYTluACM/pQSVGKgkBOp65rOu4i6bip5PftWo9qwJbCk9j0qrdIwTINUhOJz80X7th1P8AOs2RtpIxuHat2f5SxxkZ/Ksa/Qf6xPrVxM5Kxr6VcZhzyOORWm0pMgzgcdexrlNPn25HpzW6ku7B4weMUOJKZU1J8x7qh0WMyTO5wRuCAZ9aTUXxbkHrk1f8MQHNmp6s2/8AWu3CRvK5w4+dqdu56HbxrFaxKuQMY57U4n09O3GaDu2+mDyR3puCed2V+ld55A7C5BIPA496tQAqgxwCOCDx+NV0PIY52nuKtwH5RnAyecDoKTGhjDkEKM+3anMAUUsBweQe9OBTj+I85B5pgJ2H5sc8e1IY/wCUkYJBHr3rzvx3pQtrozxgg/fPoQeteg5YO+cY4zx3+tUPEliLvTWfBYx5Izz9R+VJq6syoS5WpI810yb7gHGDXTQEyL94jPBxXHRD7HevFn5eqZ9K6iwcvgr1IzXlVYcrsz3qU+eKaNVJArhTkjHSn7yzFQC3uO1U0Ys5JGB1NXk+WL5CePasGbGfqEQcJnkZHbvWReH5wo/L2rYnmVUY45AIUehNYN4ChBJ65OacURJ2LMZ+6uOnerG5scHrz9apWRBYFjV0SDzA5GCMYoKjqX4chV/vAflVhs4wnXrgnqKzYWLupJwM/nWqEXClgSSPX8hUtGhFCjHqAA3tUssfO1FAUjnuasW6x7HIyWAwB2FPBZ4sJhcclvSkUZ72Jji9e5p1od25SBjGRkdKmkuSEDAbgB8xPU1RGDMXL5L8Y7D6CnYdmya7R3kzFGo2/Ll+g98UxYo9rcs7dP8AZB9cU8QSFScKox1apVjBhAGCR0wKAOfltm+cKAX7k8H86oLA0MhD7yD1+ldY1m78sMnsSM5FZF7at5jtgbhwAapMBsMCGH92FwOvPNZ+o2BeNguGwO4q9DMEZFYDA4+U8g1PMVZiUJxjjPap1TuJq55xfRPaPuYZXvmqdzEs8e6Mc98f4V2PiCyMqHjqM9K42QNZSlGHyZ4raLuYSViKwY7GhY/PH0z6GreOM4qnNiO5SYHg8N9DV08A969KhPmjqeLiafJP1N6VA6MpHJGCfrXJFMTbT2ODXYr6456Gubv4hHqcy9BuyPxor/DceFl73KWbFdzqMZIrprFVjVN/Jbt1NYulREAkcZrctUKjjgn+I15k2ezT2L4udiMMfOeAMZwPepIAWl3AnPTPem2tthy7YC+rd60baNUYA7g3UKBz/wDWrM3SJ7SPd8u3pxg1o/Z9y7QzKnTC8VXtlCvltxK84zxWjA+1CzgLjnAHIqGAkNkiANEx6ckDmo5kjUbvnJ9xmrIkjUk7hk8kEkmluApiOzEeecLkk0lcZmyoDjccnGR2FSWoUpuwGJOOoqvO2JSu9S565XpVqygYoGO3BOcYxVF2uStuCYwWVePamMIzGd3DZ4GOlWHD4AiwEPalADwgsuT03KOlIloptAcBmXcc1l3cYkJKHHHzDFbb/IoCduCKzJWySNpAPoKpEmYLUFWIw69SR3rI1KxKbtijb16V0UYRDx/FwWFMuURlKn9KpPUmSPPypim6fStWynzHgj5gev1pms2pjYkCqEEhQg/pWu6Od6Oxe1Ft0TH1OBXReHIwNRt0PYY4rmHbzJYo1/iYV1Xh3I1JWHXB5r0MJH3Wzy8fLVI7JlHC89e1OAO4bvl9qCoJG7getGSx9jyfpXSeeSRjcuRnGTxipkVQM5wQw69hVZn+VBtBA/Sp4zksCeM889KQyWUAKSVIPvURI9MnuB0NOZ2IJU7sjOCOlN3EjAztpAMwFztYA9u/4VJu3YUjaSMAeopmdud4GMcYqPcR8y4wffpQB514x0/7LcuydYzkHOcqf8Ki0y5yiEHLcYPtXZeK7YXFl5u0ExjDcdQeorzm3Y2l6YScqpyPp2rmxNO65kejgatvcZ2lrL5hJPerfnBGxyQB1rHsZiMEMCcc8VMbltkjEA+34V5riestRb9eTIpGAMt7Vz2ozBpV/wBlcceta8soaJ9rck8j6VgyHdIx684zVRREjT0/ld2fwrTggWRmJHFY9gwCdOvaugtiqxqCOSeCPpUy0LiSIVSbacYAH4Vb4MZYbgAMDNVJERe2Wcg1p2imaJU6EDOB3qTYZbnEbNIQxJwAOBUlvIZ2KxxhV9/WrM1qfKVIs7W54pILN7chs7QTj5jQCZHJZ5Tj7p65FNsbJInDbEfHdz/IVporblCMXzyzHimiOIzbUILZzkmhsaIGso51Mh8xgO+QMUog2bWVDu5+Zj0rSMyrhWZOB0XoKrzyhI2cPwf4QCSakWuxQCbchCzP1PvVOdPMjYGEhs5ya14oSQSIXO4cuSBVWRXMpWQkICMc9qC4nN3NiAxYRgk4zg1UmV4Q29T8vTJ5rrZoAoyiqBzznnNYupxb2IySAMkjvVJ33Bow5svH9/d8uRzyK5TWoBMpVhzgkEV1ksQJAX5e4zmsbU0Cod3Gew5rRK2xlNHEMCwaNzyvAq5A5ktkYnPGD9aq3ny3BYcdjUtgT5ci56Nmu3DO0rdzysbH3b9jrFHTFY2uoFv43x99R+lbCj5RjA74zWVrZ3S22cdD/OuisvcZx4bSojR0xAEQfxHk/St6zjVgQOMcYFYOng7lIPQce9dJZIwQAHB6nHWvInue7T2LQyCqdenI5INWQgXhRsYnnnLH6moY5NsR2YGOR/jUts3G48tngepqDZFmCN93EpyPQVdgjdm5LBT6jk/jSWatguxAIHQdKuRqocMMkgZ5oKWgwL5ZJMxIB5wvH096eluGVsNKT3BxV2NQWUnCj2FWo9hBKAlh7UgdzBkglST/AFKso6HIJqwiyOFHk7VHUg81oXUMe0M+1u5XHSo4ZYSRCpO88/KOlPoNSZKAAmBxkfdI6VFdqViDooV+mAasncgVZOMjqODUDhn5MuI8HG4UhGTM7spXHOOuMZqi8rSWvzjkn5TjFbEtszpjIO4YyvBFRS2iiMK2WPQk881aHZGBh92WAYZx0p725JVipOe1W0UEsgXODjA7U9VbaVwVJ6g9KGSzD1WzE0LHgsB19K4118uZkYEYr0S5UbWHG0nrXFa7b+Xch1BANXTfQ56sbalaxXfqMOOgyT+VdRpc/lXaMeB0H09a5vSArXjE9EWtdXwcoK9bDK0DwsZK9T5HoVrMJY87h044p7feIU8kcmsfQbkOmCenArZ24c5PBHy8c1qcqJFBZlKYyBzn1qRQGUcnd14qNVDbQM8/yp5Cc7SWA5xSGLxkgcNj9KTHBJIAx1B60oJ2qflIz2phx1C5PTp0/GgBSAR8rcfTOKaAo4AO896DjbyMnp1pQPlbdgqPXtQAySNZUZJOARj615h4lsmtrtsDDxH81NeogEcHv3A7e1cp4us98KzqMlRhj6ilyqWjHCThJSRzunS+bErA85wRWhv42A564HrXOW7G0uDHn5D0PtWqk4IBHJHQmvLqQcXY+gpT51dFiY/uWB9DjHesMNmU+nStK5k2xnn+HH51joSZ9oPNTFDk9TYt0byuAOxH0rbtBuiUvxuBI9qpWMeAFYfWr8RCP5R/u5qGaQJhMcMNp2e4rb0uI7N6n5xgZrItVyC3JPUCt6wJijVxyADzUM36Es2VRvnZGUZBB6VnRr5Ts7O8rN03c4+lXDIxjBA3E8HFT2SDYwAAJ6fShCuUoDOiqCjEk5bJxT2fzI8yDClhtCjn8a1Rbgx4PAPU+9Y4t5PtUyAERqPvM3U/0p6MpMsAos4XaAuMcevvV+0ii84FwGOOgHA+tZ80TJH+4AMmOMc4q3pouGlJ2Fe26paBsubxHLtBUFjgY5OKp30DzyqqMfLAySw5q7LGkTAnazH+Ln+lQMo+0SbXYk8scY/KlYFpqZT27QuQpLRkfrVGeIrAxXO5c9B1rbu4QNhfgD1PSs++HljIA2Z+opFrU5meMElhlcdQelYurQLJCzKM+w6V1t9boYC/UMcgj9axLiLaoO3K4/KtYkyPL9UiEc7KcjcOvvTNOPzSg9sVseKbVVzJHkYNYumn95JnqRXZQ1kjysYvdZ2AwB14NZmtAmW2HfDVqAHOR39azdZBEtqx6c8111vgZ52H/iIu2OMxAHknH0rp4NqrtBOCMdOtcvZNtMZB5zx7V0ImCEN1yK8iZ70Ni/ax719Fzk57+laESqpyFwAeM1U0/s7c8Zx6VekYeYu0DIHU96zNYl61CsMZBJ6AVaVCnCnnPLHvVSwUkAoDj+daG1iTuwcdBTNErFyyUyMG2hx0NaflxqxQZyV5AqjZKyogAAA79q1ooiAoJJPc1DJZmX0Hl2+4OcD1HQf1qlDJ5ToT8zHpha3HJViuVOecYziqEqidz8nmY4OMdPWmOIeaCvChHxySKryqHJTKs+M4Pamyq6PsUlR2HXirNrC7KC4UnPzAdaq1ga6mfbFjI8YCsB3OafKSsWXXY+cA461pSwqhLKnzE/w1QuztYiZgUP6UIG7mQY/MlyUCuOjClcEnMfJYYAbpmrUi+URtIcHsO1ZU8jG5KLkBegqtxbkF2OCh+nHSuc8QKJbcOOSOpFdLLuYEAZY5OPU1j6tGDC3HUZpx0ZnUV0c3of3Zm78DB74rVIXBJx+Aqlpse2An+8559KvDBUk9uME17VLSCPmcQ71JGz4ek2OFyfauuiAbB9OK4HTmK3Kbcrz1Fd5ZspiHzFqpmRMhIYYAU96Fyx+YYJ70YUj2ycUqIAwJwQetSMcMLgHKntilYFTt4JpdrYJAz79dtNfjjd+Of1oGyNmKn7px3HcU3I3Yxtb07Gn7iCe38vxpGKqCG+b+lMRHM+Bhf+Be9UJ41miZGB2sDxU1wwJ5Y8dBTFHAAJ4/WgDznWrIwyNGeJEOR7iqthMScHGfWu08T2Xn24njXLpwcDqK4OYeTMXXhGOD7GscRTuuZHdgq/K+RmlcsNhLde1Zlo267bPrVjzd0JBwc9qzrB/3zH0Oa4ktD0W9TsrF8LkmrRffyR8+BWTYyE8HoOfwrTVgZVHY8E+maxaN4nQabHui+7xjB57VoxqkUZBOMc4qpZIFjCpyGH6VakiO0heXHSsnuapkqyDAES/KeSSeakhYEepzzVFDIpJHJPB9qm2NFIVi53dc0xsvz3LeSFTHAwDVS2d5m2cM57g8U5oFi2leF68nvVq2Me/EYCkcnjrQPSxNAphi/fICxG3cOTinwph2ZT2x16e1RTSMEVVJyDgg0JJnpgZ4ye9IRLMdr/uwMkdc81UaYI7HLbyOORWnFaqxLMSD6kdR9Khu7JCGwTgDoOufrTC6KEkjS7XZD8/JBHSqd2U+zukh3DOSKuMu1cM7gH8fwrD1O4VXChThh1Pc+9OMblJjZ3t0t9g4BOQaxbl9zsCcjpxSXM5HPBAyTg9SKqCVmJkY4J6A1rGFhNmB4jtmkgIRGYudqnHVvT61yMSJFdzRR+aCqqHWVQrB/wCIY9M9K9J1hYr2xtUF9DbSQqQY5SQN3XcpHc/nxXDatcR3WsSyQyGULHHG8zDBlZRgufrXRQ+I87G/w7m4GwoHaqGt/dtu53kZ/Cr6/dyf/wBVUtYB+yxsB92QZFdlVXizyqLtUTLOl4O0ntWxG28MCAH/AJVjaU48lRz1yf8ACtSJgcnOWJ54/SvIlue7E3bN/wB2oJwMA/WtOBBJLsRSX/lWNZZLg59MntXSadGAy8nOckismdMDUsIvLVQQBjPbNXo44/M2gjB74zUcSb1woAz3q7aweWFyPmJzSuaS0LtmkZDcBh6DjFWUL/wx7Vzj3xSwRbV+UYz3qb5ht2sgGe/U1LMblS7jj2GRUUufl5PJqn9kEMRZlCg9lrWmLJu3+Weegqq7RPIEQFWPJHUVSHFsxJ7OJlzvLN25waZHHJ5ZCOEYHkHvV2+Q7ihX5euQKrwMSx3Jz0Bz+lM1WxYd2EWdpIxgk+tZ12gfhUOMd+aklmYJskLcHtxxUd5vcoUxkdSfSmiLEEdsThhlTjn0rMuoC85C5Izn/PtXUrHtiJB6gY9qy7mDymLZIHVc1SZKZkvGSm1u3HuK57Vm2oyt2yK6GbeAxbhj1NcxrWTIQfukc/WqitRSMbTjnzlBPD5A+tXkxg+ucc96zrA7bi4XBwQDWhnbjOCDxnFexRd6aPm8VG1VkttvWdc4z6DtXcaS262HzEADp3NcGpCuM889D0rttGkDQDP3e3rWjMEa0jn6E8YoJVc4TDev+FQ5+9kknHp0qRGyBjb7ZNSA8yAqQTz9OtQzMA24ggnpnpSqehJ4x0pjsADtOQRjnt/9egBOdx3jJPUYpjSZPcHHU/4U1nOSCc57iopg2BuJz6A9qYiNip78+poJOMAEn1PekQKF5zyKbzkDOQT09qYrjpE3oV3DBGPrXA67Yi2upI+DG3T/ABrvN3zEDjmsDxRa+baecM7kPb0oXYadjhkcxPsbnbxkdxUdgB5sg6c5qW7TKBk6oOfpVayOJh79K4akOVtHsUavtIps6e0YIU9xxWvaIWYlgCe1Ylq3mbQMnb0rcR9iqSDtxjjrXHI7oHQ2Eu8FWGPWtHdsGQcjrn0rnrZ/LPmKTyNv096vW1w6y/Mcqece9ZNGiOht0UopPAzmpJUw24AZ9aqRXKNEQSQO9TNKjphCSOPqaSGxlwcnLDIqkt0Ml0OTkg4qW9QuDhwAPQcj61nIWBYYHzYwBzj3qki46o0xIZZFJJ29yKuqQjImAAehx3rNjlRVG054yRT1uWHz53egHaqSFJHW2bx7PnDKemT3qrqlzEqkdyMAYrC/tLYhG7DgcjNUHutzCV2LAdN3Sjl1M1F9SxeXe9T5JHHG31rmbyTzA2T9RmrN5eF5WZRtPPPv61iSFm3FSDnlqtGtrDChLkE/Ko+U1SIJud0eShOMelWZ2YxBQMdjjuadbOsDoZUQ4P3WOQcDvVXCxoOl2mnwfYpraNPLO9SyBi2Tyc+teZao1y2rXJvpEkmwvzIysMduV4rvNW1m2WzcnTLJseqt/jXmwuUu7ueaO3htlOAI4QQox359a2wzvK55uOdoWOqXvkYx39arayC2myMvO0qSfxqxgE5znPaq+qrjTrkHptyPwrunszyIP3kQadKVUAfWtZJs4we35Vz2mHftU5x3rXYHbxxnn615Elqe9BnRadICVUEEdDXYaeS2wL1J21wejyhpNoxn09K7/RkCsCRkEZ/GspI6oM34lCKWYjCVPHOZWUJt2j+Kqznemwj5alsHADBhzngAcAVKRTehtwgFyd49xnAFSuq7ELD7vIOc4NZ6t8vyfMxOTV2KZfl3BQScA5xRYyZL5bGJWlVhnliR0/E0nlkZKozK3RlXoavpFIcYicow5PmA5p7oZEMeyXYQQQGFPlJ5znLtGRVU449sZrMuJERGLqOB1HrW9ew+QRs+dcAENyQfSuevowlzu3cDkimkbJ3M/DvKGMnyHkD1qU3DebhlDKR1xVjETEEAbTyPaqs8BiYvG2cclfWgu+poG4RflCkMB69ap3e6SLzOmO3oahEvmJuUMHHUEYxT5Hwqqy5J6+n1osZtGZcJkgScjua5fV1HnYHPr+FdVOxTJY4J6CuT1j7ruTghiOauO5Mmc/a5N9cBf7vP51eEhKjDcjv0rNsGJurhh7DNXVIx2P0r16H8NHzuKf71kync/Iyo/Wu28P8A+oUDg8cmuIg5nXrgf3etdxpChbfPUjn1zWrOc0WJ27cAep9aQuoI69OBTGZtwPUdeO1IWYNwQcdeOBSAezsp3bv06VE0m5vvZOcnFMZiQcHI74FRFwGx0x3oESOfnOOmeB3qMnBLHJOaM5Bx65JpjHOdxGKAHSu3+znP5mmMRjsWzk+1ISM8DAFNZugBAFMQrNkHGMd6r3y+ZaSIcHK9KeTgDjjr9aZI5MbAcZBANCA8+nBSV147jmstR5F0B2U8H2rW1Di+lB9azbpfnRugHBrKsro6sNPllY2rFgsynNbok/cgjr0/CuXtJChQk9ODXQWzr5YBIry5o9uJswOEZVPY4NW2mG5T3xjIqoAGVcdBVtIWYY49AfaszVFu3LjcqNyefwrSiZcAxde59qzrIEoSeZFJHHpV8KjHCk/MPXnNA2QvKJZDGCNx+8M02JJI2VAeSMKPSoyEiuGA6Yx8vrWlaATIoUfN2FF7F3K8toFZwxA3DJGelU7l5LdhtIAA6npitWazUQl5PnYcjtmsqeB53PzgjjKdfwq0CdzN+0eeSHy2SegxWjDGy2xHyuQMgMx5pt5aJDGSkaK23CjBA+v1qEyzRRL5oyWHDk5xTGyndxTMwXZzkbuaEs2WFpMfge9OiDzB2LkZPO4VPb4ZeWJYDrnAAqWxsxTH+9bYSD6GsXUyUnGGwcE8d66a4i/el0TcT0Pasy9sVJDyMC5BwAelEZWFc5TXXnks0t7WN3eU4UKpJY+grBiSCIPHHb3MEyELIJmBywHPGOOa7rUbqJNLEkbTfaILdrZVRCUiZz80m4e341yWpTxXF0DE0jrHGsJkkGHkKjBYjqPxrsw61PJxsrrU2FJJpl+v+g3Az8pjJxT12kkimXX/AB5T+oQ5FdsvhZ5Ud0Y1gpKoyDAIxW0shdFGckHPSsvSRuiCnqK2LaAcMVIHTr1ryJnvR2JtEmC3m1uhNepaTtNuGXBO3IryJgbe/RgcAnBr0XQ7lhb5B4ArOSvqdFNnSNK0i8fxDkn+Gp7GRV5kPA+7jvVC0ulmiGRtJGPpRJLkgK3IPHNCRtub8Vw3nKVBx3q5YMAWMpQ5bOG71z1lK7gLnleSc1fSZi5ClQAMBg2CKaRnJHS/aU8s/IgHXJzikjv0WUqqDYUwzKOnsKxY5JAg3MJM9STwKY8z/KoKRsT1U4oJUF1NS6nRm3MmzIAGDWNd2/mStgA4GcEVZDRqx8xwWUetTGdDEcDrzj/69Zlr3djHmCmMg/I49BVO6bZGiJyx5JJrRuQEOcZBGazJo+XkkxjH3aaKTK6y7pWGcZODzUjXYwueV28cdarRrGsrPzkjvzVeeYMxVQCwGQRVMb1I9QlaZ2C8KorlNflEcbIOTnrXS3LeUuS3JHA9a4jXpjNOVQ+1VDcyqaIraZysjZ5ZuDVwli3GeOtUtOXFup5zkn9anYhTwSc9q9inpFI+brO9RsvWALXCk9K7mxXbAMgkDpXDaOc3ADYruYpdsXIA4q2ZFgOAeOvaoXfDYJ47+maj3Y4Bxnv6UhYs2ABx3NIVxST/AANtxxxTewzk4680khOABwKhBPAzjPODQK5YDYU9+aiLDAB+8falIHAGT3OaZ0OQR/jTAJGIIK5OenFNk+U4PLegNBYKCecnioDJ0AGGPFAEjvwo/X0pH4ViT/SouQvv70meTzxTA47XE2XpwKyphujYE+4z3rc8SqBcbucsOtYZ9W/KpkjSLtqT2Z8yMEdRWskjIiHPWsKwYpIy5710CLugCkAHsfavLmrOzPepu6TNrT7ovGoOAwrVhuc55BFclptwRLtYYx2PBzWt55VgOvHOeKxcTojqb1tcL53XJJxxWlEAzAqOFPU1zlswlKyI2M9fY1vWeEiOc5IzmpaLLU8Y425BPzZ96fCrKA4yB1AHG40RqZEVlYfQ+lKjEErn+LH0pAX7FPODhienK4zgelQ3KC2uQPL+T6Dj0FLFcNAhYoS2eTnFULm7WSXBYHd3HPNOIkRaqyykg5CEZbHIUVj3Qd4EUfKqnALDrUt7dMUKq2ACdwyKdpgaaIsvQ4wSa02L6GdagxNIszlc55bjFNSf51WLcwIxknpW7qNvCISpALY6ZzzWNOIbOMO23eOw7VF7he5bjg3x5zuUHtWFr16lukipgv6CoNU8QsrKlkST0AH8652ZpiGlun3SE9j0pqL3MZsvyzG80mSCC6hiRbVo3hklEeJSwO4565HftXM6zNHPeI0cyzssKJJMvSVwMFv/AK/etnUWuU0eyOm6RbXokQmSQ2/mtvyflPpTNbgiNjdE2dtbNbiAK8IxiRh88XH3sdfau3Dqx5eKewikbeKhvzixnGeq46+pqTPbP61X1Mg6fLngcc/jXXL4WefBe8ilp7/Z5A3DAnFdTa4a0wMZ9a5mFd0IYdQen9a29PnwAhywznHavInqe/TJ7u1L5z17Vv8AhWUtDsckMDtwe/vVdVWSAOOucGrthD5bBwccdazT0NUrO5rRsYLhtx+X2FXJmMqjyT8xGetVHwVPmfeC1Dpzq0vzsV6gE9KuJsn1Ni1dQUDE7eRkHpWpazqXAzyeMEA5rn5cxthCd2cgY4rajYxeXIHXkYIx1PpVWEzVwjjgIuOuRTXkGCpJY/3sU1pWTDoQvrx1qGN4grIgZnJ4BNS0SgnzsLxcNnGDVW3uAqssjMDu69K0uFX5zn/d7VLHDFK2ByQOc9qmyQyuWUgAcsQO/QVSuotxAAA7/hWw9rsz5YAI6e9RPbM+Sx6jpioTsxXOfIIU7UJY5AB/nWNduROTnHPSupuUWLJxlvuiucuozukkfkg4Jqr3GYeqTs0YO75V6H1rnrtBtdvQE1qajLuuEUHjd07Vk6kdsD4PUVpEymynaH9xHg9qmddx9ffNRxfLEik9hxipARkk8gdq9mKskj5ubvJmhoYHnjjNdtG52Lk9vxNcdoKZmB4HpXXrjy8cZ9u1NkAxIPQ8e1ML7un4YprE8ZbB9e1N352kjBHpQIkLJszgj1J60m9cjHPeopCHB3dvTvQvA56egHJoAe5Y524A700sFHTk96Yz+gGc85prZY8rx7npQA2WQ57tilBz0xwc+9IOSRgY+tNdgB8oBPTIpgSMyj/aPv2NRqS2eQGFMkbI4xupi5GSDz3NAGT4mQtEpAxiuWySDXYa2oks2UHJxk5HNccwweT0pMqIsBxdjtuFdBAcIqjk9MVzQP7xTnvW5FJvRD3xzXnV4+8ezhJXgkPucRXO8YHNXoZUlKMrdsVXuIVuLcep4/Gq1qGiwCeVPP0rB2OxXR08OUUbB8o4NbmnXPlrtcZVjwa5+0mMyfIecd+9aMLiRVBHC9PTNZs0R00U67SeCx7D0p8UG1SScZPX1rL00AbcvzjvWoz70weGHTFQPYdeOuwsCARx9aw712jQmNSTnoK17gB4trkEY64rntVle2j2xOxye/Wqiwiype3A8rAIZxznsPWqFrqywSFFfBznA4AqCbzJonYdcdSeDWXJZSqpZlwCfvdq2SuUzpZtX+0AojLnu2evrWPqEnmAAOG3ds8AVTs7OUyjJbYh5x0NaP2WMDKsVz1+tLlSJMaUrbowQgyN3AqlJE0ihnBwTW9LbrHJnbx1zjrWbNJvlyPuqDxTuRIilhsoIo4zbXMs8lq90WS4aMNtPKAD0FZGuRRQ3iC0jMNtLEksaFiSAw6nPerdzc2tpc6a091qJkw08X2cqEiycEDPfjms3VLlLy+eZHnkVgPmnI35H04x6V20Fpc8fFO8rGsVPHWq+oqRYyHBHTr9asZIPHX3qO8HmWk6nPKHg10S+FnJB2kmUrI4ODnBJ6d61bM+XIQDgdB/WsSxy6oepxxz0rVtTyCc8frXkSR70TpYZMR7eR9K0tMnLgKfug455rKtAJABnrWlaReUSo4NZ2NkbEHLMvPzHirEyKsgCIc5GeKzohtlUO25Tx9K2LeFZcZ6jvTTNFoTLEzS7eAFx8/rUhSUMhEoK54x1FRFGii6syjt6U2K5427CgHQkdauLDfYvvcMRsLb27HrSws7sYjuUeuOSf6VXtkTcPvAdznirRdIlJEmGJ4NJu4rWLA3JxMxJzkjOau28j5wBtQjk1i+ed7kZ3jjHpn0rVs7hEjG9/nzUS2C1jWB2IHc5+XgUyd1ER3nBxx9apPdpuyeT0DH/CoJbjcrYOT0rOxNivfOACzsNvQc965zVW2oPQ5BX1Nat8pLKW6D+EjNc7qQffIznrkKD0HFWh3OduABcMfSsbUX3JIAe2K0LiUozBieOKyWObdc9Xf9K3hG7Rz1ZWi2PAbAHHGATRnHUnjtQGwcH0pGYkADGK9c+eNvQUJbIJwDXTkjaNudo/zzXOaFGBtYsR3wK3mByWOM44yKbJRIVY8jj6mmFiBnoR1z3oO7Azzx+VRFgVwQxPTJNAiXIY59PSmtgNjrx60zfxtxwOpFIzgnGCAOwNADy3Occ98UM4OQMgA96hPfa2aQse+D60APbIfAPNRkDIADljSh+D8p+tR54IQ4PegCQkKrZz0/OoQeMAj2FNY42ljz6ZpQMkHOO/0oAbdLugkA6EcVws5Kytnjmu6kUeUxJBAFcTd4Fw+BjmkxoryPyp9+9bNoQY8A8jBx7ViPgjk/QVuaaoMYx97GM+lcOJ3R62CfumvbASJtLEEjOAKjSEE7+MNkHIqS2VvLQq3IGDgU6QlGwPuk81xnoJkdkkkRbax4PT0q7b3UtuzNjchOR2p9nGsjbgccYINXJYEUZABA6g9Km/QpEttqCSOn8hW5ZXC/xMDx681yLwMjl0+71x6/StK3aUrkoSCMjPak4jub9xcQiMgNgD0NYd9Ily2V2lgOvWlaL5ME7i3JHBqWC1RMM8YB9RzSWg0Zgt08ohsAt6jiqlwVIIYqV7VtX1soQjy9y9Rhqxksn8wsu0Jxt9a0i76lbhBcHzmWEH7oHT86srauylmP0OarwxNC5wwRs8/Lk4q+0zRwfvFYkDjApsDKu85KkfKB61zd7IsUT8gLya6PUJUkil2NtwPxrh9V1FLflo450U5Mbk4b2OOaIq5nN2Rasbu7ktLA6fqenWiYbzIZHXcXyfmOQeox9MVn6u073zG6nhuZdq5khIK47DgAZqC21SzJRv7C08c9cv8A40l5PHPOXhto7ZMAeXFnb9ea9CjseNiNzbQkDnGD1qO9k8mzlcf3do+pp6k/L3xWdrUn7mKMZG5sn8K1qPli2c9KPNNIr6YxKhc/OOldFbgBVf1rlLCYRXKgngnFdPZsSmzgjPFeXPc9qDNy0VlKsDjvW1aqzS7ugx3rJtskR479M9q6C1UeWNxHPB/xrJnQiO5idCDyOc5BzVi21EqNshwCOCKspLGUWOUBgT96qOq6RFP80EhXHIx0NJMpMtzXizqoWRiNvIz1qBbwgkM4IPGc8Vzkq3VoScEg1Ve6nH3g6hu3StUtCk7Hdw3KCEgOGY+p4FNW8ZSwU7mA45xXI211NuC/OAB64rc0+YiQ+aQWIwDto5bDuaMt+7AMGCyf3RkkmnJdOm0lJC/BPYZ+lIHVJQWLA/3Qcbv8KVn/AH0aqQQRzk549qVxlyG5MvLNjacY61q2+GUKRjJzzWNawiDBk+VhzV9ryNEGE+bPVu1ZzIkWL2SNUIOdx6cVymtnepOMZ4rSvtQzy5DY6VzGsXjFct1PQA0RRmzndVOD6k8VRkfEsSgYAUnFXZo2llBYcn1rPJ3XzEkcKa66KvNHJiZP2bJQ3tzQMFweVx6U3dxxilhYl0BxnNekeIdbosahFfOCPUVqSSLg85z6dKztNVvJG7/61WiAODls+nrVED2YkDccgdsUxnY9VBHrTSxB5yaTIAPUE84zQAbsZ/SnDJGe9R9T1zk9qUk5Azg9xQA89MkkAehphOG9Ae+aTndknikO7eAB36mgB23jnoTwAKCuOMke9NLNzznjpQxKElv5UALtGPUU1yADt4FMznoAAaYxIYY7elADnPyOFA6dTXDXxJupO7Z6+ldpIf3bcY4/OuIvTi5fI4B6UmVEh6lRx1xXQaQRtCt16VzyndIin1rfsTtYZGR0rhxW6PUwS0ZrQExTSRk9fmB/TFPu2RYwc/SqgYtcoM/K4wT6VNc5SAggN6VxnoF/S2AAZep6rngityOJJYh0C98GuY08mIR88d66GFg8W1GCn3qJbjRBLA8c24NtbOcDofrWjah1OeOe4qKElnIAyR1VuatsuUIX7qn05oLLccaABpVVkPBJHGP6Ut2II41KxgHHT2rPtpTAWBb5WOSDyM/0pl807lihWQZHBPIFCVwEvLmKS3xHGAB1wxrPtnSOSJMYAJ46k+3NWUtmY7VC4P8AtjrUU2nyHHyjf1Lb6rYtGqbeO4SKZVVGH3s9RWddyQxzcn7oJPcU24keKNB5gOB8wFZGoXatnn5T1IOPwpaisUNXu1McxjCg9jjGa86vJUN5GJ4vOjD5aMNt3e2R0rsNcucRDBBA+6MdK4yeI+aWbqTnNaw0Oaq76HSWenxXVpDPbeHiYWOVZr4rnBwTz2zWfrNubXUHiNsLUqq5iEvm7TjufX27VPFdRPHpwuIrkJJC+nOVTKnJyrJ6sCRkVFr0qSahtRZR5MaQs0q7XdlGCzDsa66Gx5uJ3L4784rI1k7rqMDoiZ/OtNQRzz6VmzDzL64Y9BgZ/CtMS7QM8Ir1LmXkifjFdFYT7kAB+bpXPqmb0BVyOtawBiZZFAx0PNcMndHpq6Z2ul3CyRiNiMrwM1uwSGNlI2so/OuH0u4KSA54PI9q7DTHSaFcHLdSPSsXodUXcsyMZCxBbO7IQetXolkWFcoWGOhPSqzRJ5gYg7Aefep1kIkjRmjaPHBGTj8auyZYeWsi5KuwHBAHAqu+lRzzEKGJHTnHFayXKQRSAqAvrjg0y3vYzBuiVSw6kKOlCRRlNpn2fLqRleGB9KdFHbvEjELyflySMfh2qW5v1YLu8xAWz06n3psTGRg8ojGDwRgZ/Cm0wZfgsIg4bywV/vZ4/H1rWisoyu5VKjH3TgD86yra8jiG3cuQOATwalF/LKMDJwPTA+lYyuQ2zQlEMcJOELdu9Zd9OgiO7qRjHpTZHdizNhvbPSqahnYPIBt9T0qESVp5d7bVG1B1Y8ZrMe28x97ABR2NacrB3IB3KDkmopHXb8y/getaLQTMK+QRbmxzjIrmhzdvn0xXQ6s5UtnNc3CzGeQ9Ca68MvfRxYr+GyyMDGKntMGcAnvVfnPYfSrFiT9oGRXoo8dnYWRxCCAQDipXfJIXPXpUdu58kAA4I7Up+XcpPJ9KozEAZwB0PTmlP3uCKCHwhyc49aUkKenOOnvQAq5+6OtIA3AKZx2zS564GPcUE7cdTigBrDJIxjIyaXLZGBk+h7ijOMHH600nG0Ec0ALJgct+lNc4HzE7vSkDDnP51HvzkAZxQArOx6AUw4APJz6mmu+Ow47CmMSM+vvQA52KxkgZ+Xqa4i9OblznnNdjMw2N1PGa4u9YfaJD71LLiMRh5qgjnNb8T+USDypxXOQn98me5rpIgJCme/8AOuHEfEepgvhNGBW8nepzg5xjrV10EluVAwRg59c0WkZ8pgflHr9aZHlEeLbuZPlPvXGd5Fb5QbWP3fWtK3JCYDdicNWWQVY5zg85q1FPhcL1zn6UmCNqzlZpQWUBiBznitULkZI+dh26Vz1ozKzD5dpPStFLtldduc/XNSyzUSzDtvzjIweOtMuk8sBk2rgYAz1pr3TMqtFnHtUUu6RWLgFfT0pJjEtuH3IysynqB1qe6RCrLuUMcEkd6znuRbgDC47tUFzqDKi4YEdx6U/QLjL9XJJUAA1j31pHbK0kkgLEZIzwKmm1Dgkkk+9c3ql1Lckx5JXv/hVK5MpaGZezfaJ2IOEH3eetZsy8HA+uBWqIc7VPAHtVKaWW2nWSBzHIhyHXjFWnqYPuOlNtqdnp6SX/ANjktl8sxyROyH5id6le57/Sm63dR3V8GiMjpHEkXmSjDS7RjeR71ciuvsNlpwn1zULbzVLrBFCHCLkjOc9DS6/ZBhLdjUZb2WNImcyx7SY3+4ykdR2rto7Hn4ncjVuCBn61npl5bojruNXUfGMDPpWZC+2a6BP8Rp4v4ELBK02V7fJvV+lbnlbwcfUe1Ytk3+nZGcDrXT2+C6/7X6VxS6Hox1KdszRSBWHBGRmun0ObynJViSecZ6VkXEK5BA4Aq5YKcI8eMgcis5GkXY7a2C3KLlgNvTPrUMtq1swJJZRnJA4rO02ct8uSsq9QeQK3Y5kuYgrEZ6ZqoM2i+5QurlngEce1xjuKbpaGOINGjBAfmG7rTZ42iE0L7hJ/CcZH1pLYXlraqocLzkk4zWl9DU0H01pZBLyd3RSxytE9ikKAeeYwBnarZIFaOkC5aLdcshxyCMcj6VcW2jlYs+8Y7AgVDlYlsxbOxDxqxEjBTwx5B/SrwjWIfcy2c5J6VpTsixEqFZAOpJJz9KrRxRyN8+53x9AKxlK5L1KbujnaijOeTVe9VnhIYMcnnHX2xWi8IjyEUkdlHA+pqocyk528enb6VIGdLHtjGxNpA/Oqt3GyJlhhvQmtpyiDJAAA4HcVkX0hwWxkKOc96tMls5LW3ywAPGawo/8AWv8AT+ta2ptiQZPrWQhPnsTySK7KHxI4MVrBk+SO45q5pfzXIqjuxnGKvaSc3IJxXoo8hnXx/Ki4PAFJzn5RyfekD/IARljSgkHnpVIzFAzjJwOhwaXCqBigr1IAHr7U1nXJJ4+tAC5z14x6CnOVIGf0qLdxkED+dNBXBIY/jQBOZFIxjio3J6np6etM8wA9ck+1MLggksTz3oAduHTHP8qaSOmabknnqPalyRxgAjtQAm4FQFFNcNnJ7U7JXnjmoyR6jBpARztiNumCK4m8/wCPhgOma7K4I2HbgkiuNvuLhiT3pMuJEvEi/Wum0+ZRGu7HbqK5YtznFdDYPmNcAYrhxG6PUwfwnVWrhoCOnPNEv+thYpjPcd6ZYMuAM/ganmf93GuQGVsgeozXD1PQ6EUqBlAA4FUmDI/Pbse9bZjyWYLgmsu5iZdxODkn9KFqIu2TCUKGzkdRmtABRgqffJ71zsEjq42k9s1qRTnBy/tyKTRSZqLcBEXJHB70kt8MYj57cc8VQnTKghsg8kCqWDGp8ogDrzSSHYmupWmOcYI4ye1U5IWK5zuz3x0qckGMMSN3eq91e4jEaHcfyppg3YzL2VkBVDwPvE9aoE7eTkn+VXWUzSZXBH9ar+UVVizde2aq5k9SsSSTubk8DFZOo5GOe3IrYmIAxj6j1rG1BgCWPU047kyLtk0YtbIaw+m+WEY2q3MbvIEz1+X+HPTNR6zdXqPc2lz5BM5SQyxDh4wPkC+iAdBVGz1GwuFVNTtJ5ZLZPLjlglCFkySFYEdvUVLrjySXsbSxJCpgj8mNG3BIsfKM+vrXpUV7qPMru82TqORiseVyl3dKcA7q11Y47Z9aw9UO2+lwT8wBP1pYhXiGFdpkulDdccgHJ655FdXapugQfxA+v61yWkf6w12dgqtGpxj2rgnuenDYkjUhQHHI6n1qZImilVhkxt3HTNSBCI9oGVz1NW4R+6BHJ/nWbZY+J2jIePBz1Ujn8KnXdLh0DRyZ544qCN9kuwDkHp6VqRSxjKuQCen1oUrFrUnjEu6N5pCSPftW0qwSxIzeW56jIzzWfZpvfJwR6ntWvawQopDNhR+tJzuzVuxCjOjZCxFT/CO9XJJ9gUzYbPQ44Wq08hTIjwyfw4UDH41RPnTPlyduf4qp7EXuazXQmIXkp2A6VDhosFujHp1qrFv8zGTgdPSpLhnZFVsAdiDWQ7jnug3yyDJXpzVeedQpBZVPv2qs6eWd3LEnqe9V5tzuAeAW5BpoTASO7MXY7QMjA4rK1C7/AHe1Rg4zz1Jq5fSbCNpGwcn3rEu2L7nY5HYepqkiZGHqAy+7II6A+tZj8SAjvWhd/M2M/dxiqE42yqB9K66L95HHXV4MBj1rR0cjz+fWs0HFXtKbFwAuMmvSPHZ1wbAGDxTxzzgj61Epwp4/CkD/AC43Z+tMzJGYY5PPtSH5yDke9MDjaeuaQ44259zQA9iB2zj0prOQOMdOKR2+UHOcdeKYDuAPIOKYErn5e/IxgVG2AAeQTTgcDAGT70dQc9u1IBqgjgHjrThwQQc+lHBX396RmJ5/CgYMcA46moHYtkcDHFLI/qeB2qL8eD3pgNkXt6frXKamu26dcjNdbjLHmuX1lAl4xI4IzmpkVEz3Hyelaekz8KGOO1ZhYEEVZsWCsR171xYhao9LCuyOvt34RlPNasbB5AQFyB0IrD02UFRnGSfyrYABYNnaR0964Xoeimi9DlY/mX5u5J61Fcru+XAIz2PWrEbgxgMoJA5NV3BaUHjgfnWZRWWHyxwCfb0qOXdsU5AYVebIZvnUd+arTkMCCNxPY1SAhRpi2NxY4+7ml+Ydsn0qzbxcK4O3HHXpT3+Vc4IOe1FwM1w64OSR6elU5IGkYDfhe4rSuVwA7dMZANU4txkyOmOvekJjZFSJFRSeOuO3+NUp3Akzjp2/rWjKiIgJYluorOlAAztGfehEmfcvnoMc8Y71k3zwLMpumk8g/e8rG7Htnity4RVBYk5A6Cucv43urqOJGRXkO0FyFUH3J6VpDciWw6xHh8+cVfVuwORHT9auoLu8R7USiGOGOFfMxu+UYycUWvhzUIRKkrWKSB8MrXaAg+h5qteWz2k5hlaNnABzG4defcV6lP4UeVU1ky7xjrye1ZGsKRdqx7pWqPlHJH4Vna0Plhf3IzSraxFRdpoTSDmXrhia6/T2CquePauK01sN9D69a62zdjg4whH5V51Ranqw2NiBj5nytlWHHp9KvoqpGNoI56VlW7MpGACB1FaiOHZMAhsdOxrJmttB8ajzMsTn1x29KtwwgMCACvpVeAlpMKuF6cntUzuRwOB06cCkNaGzZ3McWN+R2q42oKB8oyvfBrnfP2ptbrUyyq+AT8vrikkUbqXSHJbBU8Yz0ppuFbCoML1JPU1jFw3KHJFQvM6sSxYdAFFaW0F1N3z1J+Qsfb1pss8f3Tyx6e1ZMEzBcnJY8cUpjYlWfDA+nGKiwy7565I4b+lNlcBSw6ngk/yqqrbEYKFPPFVbifJUnhfryTQkJjb6Q5Kgg+prHvJcggHGPTvVqdyTy2GPP4+lZ0gLMyr+dWkTIoPktketZ14378AepraZVSN+Oc5rAuzi5UegNdFHWSOavpBgW6bs4q/pGfPyorNLE4q9pTfvx9a9O55FtDsPMAAyQaaxz06DmoQdwALDH0pRJ3Y54pmRK3HzFj+FOBOPl+oGagEnGTkikMpYnPFAFkkk5OOOcUDjqevpVZpAMYyfUmnlxzhuKAJd5BIx/jSFwR8v41D5mM7RzjGc00MOc/nQBL5h/iOD64ppYc8mo2Y4AphbBxkZ9aNhkjHJxwMdxTWbGen41Cz56dKidgep49KLhYlef5uoCiuc15y9wMDAxW0vzHgcd81k68uGU55IqWy0Y4JJBPNWoTh1warHqMVIwxICemBiuWv0O3DPc6KwlIBAIxW7FO4UE8jNclbu24KO9b1lMTwOOx9hXDNHoxehuQORnDcdqkkYlgASuePrVOMq6/eHX0pZiysTk5HA5rOxomWlVBnn8WqFCkzlF7etVY2ZpCM5U9sdKmRweGBAHQe9Ay9vQjluRxwKax+UF14Pqf1qlI+3kn9KrvcFuF6H17mk1cQ67IecuCcDt2pItrRkyHkdMdKWIJj5z8x6nrSzPiMhRznIPpSQmVp2wrkKwI6CqQYPhhgr6e9PvmcRhWcD6VFGfJhA3Zx3xVIlla7Z2UjgLXN6lC00qwxRvJI5wEUZLfhXR3MqhG4AJGPrXK6k7+aDCZPNLAKUzu3dse9XT3InsXV0/V7mJJbmwu3k2hNxgOSBwM8cnHeqlzFLayGK4hkhlAB2Ou04PfFblzYa7dSrNKginZFDp9qCszAckru4J7isO9jnjuJI7sSCdDtYSE7h+detF6I8qS1ZbLZGRxVXUl3WbHPKkGph9BinuokiZcckYokrqxEXZpmVprESexrqdPY7BjvXI2mY3OeCDzXTWkm1VbOFNeZU0Z69N6G9aqEdSTnJ+6TWtZqZEdJdvJO0g8jNYts29UCDJz8pJ6GtGGYcBiQ+OQR1rFmpfdWhKYYkDgHvmpHfzMf3umDTPNUqpyGHQgdRSDbI2DgY6djmkUW4lXaB8u5eo71IBk4OAPY0yNNgV3znGD9KlARyQeG7YpDsEaqGOcZ9R1qvcf65QCckelSiMKThjleKikceaefmHTmmA+JyTgAFgeSamQlgRwEPB96rqwWPJ5J7etCs7jhVHP1pAxx/eNtXr16dqhmiIzuwAfxqVwVXK7i31qNwW5bJwO5piZk3ABlyThTxxUbDaQF78E1Zu1DYABIB+lQMNvU9au5L1K14wAJ9OAK5i4ffduc9q3r2XKtz14HsK57O6SQ8DnFdOHV5HLiX7gtaWjjM4IrNDDIrW0MZfkAjNegeUzoduR3zimjOe2KdkkdORTSTn+EE1ZmOB4PH503cB26U0qcc9aNp54xQA4MNoyaapOSR3oJA9MdqQ9P6UAOB465PpSEn0zR/vdu1NJz1Jx9KQCZJOQMAdfekIGc+tDE5xnimFsEDBxQOwNgDqcUhA5OO/GaUgbucGmu+VGODnmgYZweuKydfGI4yR1rU8wb8jn0zWRrzZjU8nmkxrcyM4BqxgPD7iqZOR161ctvnj/Cuav0OzDbtFy2bO1jwcfrWzauVVWU445rCtT8oDVpQF1BK9e4rikehE21BY5Q4PepvOxt2nJA5rOtp22g9PWrgcbclV+tZM0Jo5EkUFUwxP0qXPOP7oz1qiSzZy/yjpjtTWcKeOfUHpSHcsTOWYsSrjNU5Bsdn+6R70RFjzgKvUd6Y7B2w59t2KQXLUEhLBySvy8+/0qOYxhd3zAk856mnzxbETyznP8VUdQBPA74xigTZVklDKxVGzyF3UeWxXLZHHQdqdAuCTsBx3p0zkrhRx3z3p3EZ15vWP8e9YdvefY9ZtbnbvEUm4rnGR/Q+9ampSh+uQPSsnRJ4I9ftri7H7iKQbsjOPfHfHBrooRvIwry5Yl+ax0gSFpL+9i3/ADbJrP58fXOD9ah1u6F1eoyxyxxJCkUfnffZVGAze5q8+oNJPPp+uXYvLZydtyjbzCx6Oh9PVar+KGjbUoVimjnVLWFPMjOVOF7V6KPNGBRjApcEdfwpM85xTjVEGLeJ5V445w3zCtrTZVYKG6DgiqmqQl40lQDdH19xUVrJhgVOAa4K8LM9HDTvE7CzODhTkYzV9ASflAIJ3DPUVkabIXX58Ag1rRKQcndx2rkZ2EhlYqQ2CB3z1qe3O4E7SMc0zaWU7SBj15zT1iycs2OOgPSoZSL6yFYcOcA9+uKRZgswABzjr1qmrPEcKmU7H0qW3kdpMAcDnk0Io0TGdm52Jz1HY0k0Q7DBAA4FMEsm3YDxnj3pSxyw3qCO/pQIah/dAYA9zSqwUhg3AHAPSoFY8q2c+1OwPlPXjAzTAeW3rxgAnqKaWCL8x+X+dNDfNsAFQSKxLbz8p/CgkgkkBfJGAegqrcy8HjHapZcLxkL71nXUwIwBx6mqWpJnancbQ3fjn0rHhz5QY98mp9TlLMRkk5qJQMKOnau/DrqcGLlshwJzxW/ocOAWJrBQEuAK6rTflgGBg12I4JF7OF4xz60jDIBwKiMuSDkYHpSNKmTwaZFmSl80rENxjp3qDzgQTmmmU5+U80XCxPlRyO/FIzBVBIxj0qu0zHpn8KYHPTpRcLFjzFIyePrTZJCFABwKgYtjp+VNOccmkOxM0x6dajZ9wHWmYOM07jqaADdx0NR7zmlZ8HA4zUYO1fm60APPTj86z9XUNbZHWrobr71BffvLVwecd6GNHM96t2jfIV7g5HvVQjBNSwPtmGeQfSsKyvE6sPK0jRiGHBHQ9q0o3xyT1GKzFO35uozxV1MSINvfjmuCR6MS9G3O0jnHOaeZSsfBJxyKrrncAR9CKUsyv149Kg0LJvMpgqRTROOqsCT3NQLMkjFd3I45oAGcE/L6ikwLUcwB2kEhvXtU0wCogEgXJ6+oqmspA2jH51K6xuoaToKkCzGQsWS4bj1qldTAKcDkdear4RixDbiDxSHlsPz+FOwD4/MkUkEKuefaq9zIEGS5x0xQ7YRwrgN2A7VRupCQSxJVRnjvSsIz9UuCEYnp1rPskZlQBS0kjfKByST0FRahL5sqonO44rS0aWO31O2eRvLQErv/ALhIIDfgSDXoYaNtTixUr2RO2nRo5il1G1juFyGj2syqfQuBgfyqlcQyW00kE6FJUOGX0NdEIni1W1lLzJJDEsRs0gZmcBcFVIG1kbk5J781ja46/bI41ZXaGFIXZTkblHIB746Z9q6UzkaLSjim9M0UUzMVgGikDdMEVkWp+X6UUVzYnoduE6nS2H+qX3rctHYnBPGT/KiivPZ6KLaDaj47c1NC25AcDpmiis2Uh5Y+WO2SM4p8oCnKjBIxn0oooQEdtK7NyaszNgYwD35ooqhkEDFmBJ7ZxU44cH15oooAUEs5B6VTuHZY2IPIPFFFBPQyrhiWBPes66ck/SiitYkMw7glriMHoTk09uMUUV30PhPNxPxElpzKM10sORGOTRRXQjkkKeppaKKZIRgHNJj5zyeaKKAHxjkUPwc+9FFADOgpjyMvTFFFAxjOxUZPtQSQcA8UUUwQjkjkdelNHIyaKKAY/wDhB96bcACJgAKKKQjmJwBI+PWo1OJEx60UVnU+Fm9P4kao4iB9Oatw9xjvRRXmyPVRYj/iHtUUmQ7c0UVJZXdiJQeM5qwzkjJweKKKhgOhAG01cVuhIBwehFFFNjIlwQ7YAPtVS6kbzdueOKKKSEVZGIZ8Y4NZupO3lj5jyKKKpbiZiR83AJ/u5q370UV6VD4Tza/xk6XdyluYEuZ1hIx5YkIXH0quv3gO2cUUVqYn/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A red-blue, reticulated vascular network is present on the legs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Livedo reticularis - lower leg",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A reticulated vascular network is present on the lower leg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17941=[""].join("\n");
var outline_f17_33_17941=null;
var title_f17_33_17942="Injury perpendicular exposure";
var content_f17_33_17942=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    In-vitro experiments on human gallbladders with direct perpendicular exposure of the gallbladder mucosa to a laser",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 254px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The laser fiber tip has created a narrow channel penetrating the wall up to the serosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Lingenfelser TH, Routschka A, Grossman T, et al. Flashlamp exited pulsed dye laser and electrohydraulic lithotripsy: In vitro study on tissue effects. J Stone Dis 1993; 5:118. Copyright &copy; 1993 Futrua Publishing Company, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17942=[""].join("\n");
var outline_f17_33_17942=null;
var title_f17_33_17943="Mahaim fiber tachycardias";
var content_f17_33_17943=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mahaim fiber tachycardias",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17943/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17943/contributors\">",
"     Philip J Podrid, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17943/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17943/contributors\">",
"     Brian Olshansky, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17943/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17943/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/33/17943/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 3, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term cardiac preexcitation was originally used to describe premature activation of the ventricles in patients with the Wolff-Parkinson-White (WPW) pattern. This term has been broadened to include all conditions in which antegrade ventricular activation or retrograde atrial activation occurs partially or totally via an anomalous pathway distinct from the normal cardiac conduction system.",
"   </p>",
"   <p>",
"    The classic form of cardiac preexcitation is the WPW pattern, which is characterized by a short PR interval and a broad QRS complex with a delta wave. The anatomic substrate for this is a band of myocytes that bridges the fibrous atrioventricular junction, also known as the bundle of Kent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/1\">",
"     1",
"    </a>",
"    ]. The electrocardiographic features are a result of premature ventricular activation due to conduction over the accessory pathway. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39256?source=see_link\">",
"     \"Anatomy, pathophysiology and localization of accessory pathways in the preexcitation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several other pathways, such as Mahaim fibers, have been postulated to result in cardiac preexcitation. However, most lack the histopathologic correlation that has been demonstrated for the WPW pattern. This topic will discuss the Mahaim fiber tachycardias. WPW and other non-WPW forms of preexcitation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17370?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of the Wolff-Parkinson-White syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11272?source=see_link\">",
"     \"Lown-Ganong-Levine syndrome and enhanced atrioventricular nodal conduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMIC AND FUNCTIONAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1937, during pathologic examination of the heart, Mahaim and Benatt identified islands of conducting tissue extending from the His bundle tissue into the ventricular myocardium [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/2\">",
"     2",
"    </a>",
"    ]. These fibers were termed Mahaim or fasciculoventricular fibers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/2\">",
"     2",
"    </a>",
"    ]. This description was subsequently expanded to include connections between the atrioventricular (AV) node and the ventricular myocardium (nodoventricular fibers) (",
"    <a class=\"graphic graphic_figure graphicRef69078 \" href=\"UTD.htm?23/5/23634\">",
"     figure 1",
"    </a>",
"    ). These findings have been confirmed by other investigators, but true continuity of these pathways is less common than was initially suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/1,3,4\">",
"     1,3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mahaim fibers were originally classified into two main groups depending upon their site of origin [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nodoventricular fibers",
"     </li>",
"     <li>",
"      Fasciculoventricular fibers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This classification had a functional as well as an anatomic significance, since the two groups were thought to be associated with different clinical features [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/5\">",
"     5",
"    </a>",
"    ]. The nodoventricular connections were presumed responsible for the generation of an AV reentrant tachycardia (AVRT) with a left bundle branch block morphology that had unique electrophysiologic features [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. This arrhythmia was not seen in patients with fasciculoventricular fibers.",
"   </p>",
"   <p>",
"    This classification for Mahaim fibers persisted until evidence suggested that the anatomic cause for the tachycardia with characteristics previously attributed to nodoventricular fibers is a slowly conducting AV accessory pathway with decremental conduction (ie, conduction slows at faster heart rates) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. This accessory pathway, which only conducts in an antegrade fashion, most often arises in the anterior wall of the right atrium and inserts into the right ventricle, close to the right bundle branch.",
"   </p>",
"   <p>",
"    These unusual accessory pathways are responsible for the constellation of electrophysiologic features that define Mahaim tachycardias. Histologic and functional examination of tissue from patients treated surgically has demonstrated an accessory pathway with features similar to normal atrioventricular nodal tissue. The presence of nodal tissue in the accessory pathway would account for the decremental properties seen in Mahaim fibers, which is not characteristic of other accessory pathways. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39256?source=see_link\">",
"     \"Anatomy, pathophysiology and localization of accessory pathways in the preexcitation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two types of decremental right-sided accessory pathways, both arising from the tricuspid annulus but with different ventricular insertions, may be responsible for Mahaim tachycardia (",
"    <a class=\"graphic graphic_figure graphicRef55351 \" href=\"UTD.htm?34/58/35758\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atriofascicular connections, which account for approximately 80 percent Mahaim fibers, have a long intracardiac course and insert into the distal right bundle or right ventricle near its apex, often with arborization [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/14\">",
"       14",
"      </a>",
"      ]. A possible morphologic and functional explanation for these connections, involving the moderator band, has been proposed [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Atrioventricular pathways, accounting for approximately 20 percent of Mahaim fibers, insert proximally into the right ventricle near the atrioventricular annulus close to the conducting system [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The term Mahaim tachycardia describes the typical constellation of electrophysiologic features that characterize this unusual form of reentrant tachycardia, without implication as to the underlying anatomic cause.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Conditions associated with Mahaim fibers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several conditions have been associated with Mahaim fibers, particularly other accessory pathways. Approximately 40 percent of patients with Mahaim fibers have other accessory AV connections or dual AV nodal pathways [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/5,7,8,16,17\">",
"     5,7,8,16,17",
"    </a>",
"    ]. In some cases, an accessory AV pathway can mask the presence of a Mahaim fiber which only becomes apparent after surgical or catheter ablation of the accessory pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/8\">",
"     8",
"    </a>",
"    ]. Mahaim fibers are also associated with Ebstein's anomaly of the tricuspid valve [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Uncommonly, a narrow complex tachycardia is associated with VA block and the most common etiology is a concealed nodofascicular pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/18\">",
"     18",
"    </a>",
"    ]. This may be suspected when intermittent antegrade preexcitation occurs, when the tachycardia is initiated by a single atrial premature complex which produces two ventricular complexes, or when a single ventricular extrastimulus initiates the tachycardia without a retrograde His deflection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39481?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ELECTROCARDIOGRAPHIC FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The resting electrocardiogram (ECG) in patients with Mahaim fibers is usually normal [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/5,7,8\">",
"     5,7,8",
"    </a>",
"    ]. This is due to preferential ventricular activation via the AV node at normal resting heart rates. There are, however, several settings in which conduction via the Mahaim fibers occurs:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enhanced vagal tone or rapid pacing may slow AV nodal conduction and favor conduction down the Mahaim fibers.",
"     </li>",
"     <li>",
"      A random discrete jump from AV nodal to Mahaim conduction or a fusion complex of AV nodal and Mahaim fiber conduction may be seen [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The relative refractoriness of the AV node and Mahaim fiber may change with time, resulting in a variable degree of preexcitation during sinus rhythm.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One study of sinus rhythm ECGs of patients with Mahaim fibers identified a narrow QRS complex with an rS pattern in lead III in 20 of 33 cases (61 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/19\">",
"     19",
"    </a>",
"    ]. In contrast, among 200 young adults with a history of palpitations but no structural heart disease, a narrow QRS with an rS in III was found in only 6 percent.",
"   </p>",
"   <p>",
"    In contrast to the WPW pattern, there is no delta wave with Mahaim fiber conduction. As noted above, the Mahaim pathways terminate in the ventricles into or near the conducting system; in contrast, insertion occurs into the ventricular myocardium, with slow muscle fiber-to-muscle fiber conduction in patients with the WPW pattern. It is this combination of preexcited and slowed conduction that is responsible for the delta wave. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17370?source=see_link&amp;anchor=H13260510#H13260510\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of the Wolff-Parkinson-White syndrome\", section on 'Electrocardiographic (ECG) findings'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several ECG features that suggest Mahaim fibers as the cause of a tachycardia with a left bundle branch block pattern (",
"    <a class=\"graphic graphic_waveform graphicRef56384 \" href=\"UTD.htm?25/45/26321\">",
"     waveform 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef58895 \" href=\"UTD.htm?14/39/14969\">",
"     waveform 2",
"    </a>",
"    ). These include [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      QRS axis between 0 and minus 75&ordm;",
"     </li>",
"     <li>",
"      QRS duration of 0.15 seconds or less",
"     </li>",
"     <li>",
"      R-wave in lead 1",
"     </li>",
"     <li>",
"      rS complex in lead V1",
"     </li>",
"     <li>",
"      Precordial transition in lead V4 or later",
"     </li>",
"     <li>",
"      Cycle length between 220 and 450 milliseconds (heart rates of 130 to 270)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although these criteria are useful, they are not diagnostic of a Mahaim tachycardia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ELECTROPHYSIOLOGY OF MAHAIM FIBERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two types of Mahaim pathways, atriofascicular and atrioventricular, can be distinguished by recording the site of earliest ventricular activation during tachycardia or maximal preexcitation (",
"    <a class=\"graphic graphic_figure graphicRef55351 \" href=\"UTD.htm?34/58/35758\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With atriofascicular connections, the earliest ventricular activation is recorded close to the distal right bundle branch near the right ventricular apex.",
"     </li>",
"     <li>",
"      With atrioventricular connections, ventricular activation during preexcitation is earliest near the tricuspid annulus at the site of pathway insertion and relatively late at the right ventricular apex.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most characteristic electrophysiologic feature of Mahaim fibers is their response to atrial pacing at progressively increasing rates (decremental atrial pacing). What follows is a description of the electrophysiologic findings and then the mechanism by which they occur. At higher pacing rates, antegrade decremental conduction within the Mahaim pathway results in prolongation of AV interval and progressive ventricular preexcitation, resulting in a QRS complex with a left bundle branch morphology. The increasing preexcitation leads to progressive displacement of the His deflection into the QRS complex. Even after maximal preexcitation has occurred, the AV interval continues to prolong at higher pacing rates because of further decremental conduction.",
"   </p>",
"   <p>",
"    The QRS morphology associated with maximal preexcitation during atrial pacing is identical to that seen during left bundle branch tachycardia. However, at a critical coupling interval during decremental atrial pacing, a Mahaim tachycardia with a left bundle branch block morphology can usually be induced. The ventricular electrogram during tachycardia is not preceded by a His electrogram, and the earliest evidence of retrograde atrial activation occurs in the His bundle region.",
"   </p>",
"   <p>",
"    These findings are due to the conduction characteristics of the normal AV node and the decremental accessory pathway. At long pacing cycle lengths (slow pacing rates), the majority of ventricular activation occurs via the AV",
"    <span class=\"nowrap\">",
"     node/His-Purkinje",
"    </span>",
"    system and there is little preexcitation. AV nodal conduction time increases at shorter pacing cycle lengths (faster pacing rates), resulting in a greater contribution of Mahaim conduction to ventricular activation and an increase in the degree of preexcitation. Maximal preexcitation occurs when ventricular activation is exclusively via Mahaim conduction. The reentrant circuit is completed when there is retrograde conduction via the AV node, allowing reactivation of the atria.",
"   </p>",
"   <p>",
"    This mechanism of tachycardia has been further supported by the selective recording of His bundle and right bundle branch electrograms in patients with Mahaim fiber tachycardia. One study demonstrated that decremental atrial pacing led to reversal of the sequence of His bundle and right bundle branch activation associated with the appearance of progressive ventricular preexcitation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/9\">",
"     9",
"    </a>",
"    ]. Before the onset of tachycardia, there was complete reversal, with right bundle branch activation occurring prior to His bundle activation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Electrophysiologic mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mapping of Mahaim fibers is performed to identify ablation sites in patients with symptomatic arrhythmias. However, because of their conduction properties and anatomic location, it is difficult to map both the proximal (atrial) and distal (ventricular) insertion of Mahaim fibers. Mahaim fibers do not conduct in a retrograde fashion so the proximal insertion cannot be identified by ventricular pacing. The technique used to identify the proximal insertion depends upon the type of pathway present. With the less common atrioventricular fibers, the technique of mapping at the tricuspid annulus for earliest ventricular activation and shortest atrioventricular interval during tachycardia-preexcitation can be used.",
"   </p>",
"   <p>",
"    However, this method of mapping will not identify the atrial insertion of the atriofascicular pathway. Three methods of mapping atriofascicular fibers have been proposed:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stimulus to delta-wave mapping [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Premature right atrial stimulation during tachycardia [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/9\">",
"       9",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Recording of Mahaim potentials at the tricuspid annulus [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/14,21,22\">",
"       14,21,22",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The last technique, identification of pathway potentials at the tricuspid annulus, has several advantages. A Mahaim potential will be recorded only in very close proximity to the atrial insertion of the accessory pathway and, therefore, is likely to be a good predictor of a successful ablation site (",
"    <a class=\"graphic graphic_waveform graphicRef79320 \" href=\"UTD.htm?15/59/16308\">",
"     waveform 3",
"    </a>",
"    ). Mahaim potentials appear as a discrete sharp potential (morphologically similar to a His potential) lying between the atrial and ventricular electrograms recorded at the tricuspid annulus during tachycardia or preexcited atrial pacing [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/14,21-23\">",
"     14,21-23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The long intracardiac course and distal insertion of the atriofascicular fibers which shows arborization makes mapping of the ventricular insertion difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/14\">",
"     14",
"    </a>",
"    ]. A propensity to temporary loss of conduction of the Mahaim fiber due to catheter trauma further complicates ventricular mapping. Rather than mapping, there have been attempts to \"cure\" the tachycardia by ablation of the right bundle branch which in some patients is the distal point of accessory pathway insertion. However, ablation of the right bundle branch within the ventricle can result in lengthening of the tachycardia circuit and more incessant tachycardia. Because of these problems, ablation is usually aimed at the proximal (atrial) insertion of the pathway. In some cases, however, mapping and subsequent ablation of the ventricular insertion has been achieved with preservation of AV nodal conduction (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Catheter ablation'",
"    </a>",
"    below)&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL ARRHYTHMIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual arrhythmia in patients with a Mahaim fiber tachycardia is a reentrant tachycardia using the Mahaim connection as the antegrade limb (since it only conducts in an antegrade fashion) and the AV node as the retrograde limb of the circuit (",
"    <a class=\"graphic graphic_figure graphicRef61702 \" href=\"UTD.htm?16/35/16944\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef56384 \" href=\"UTD.htm?25/45/26321\">",
"     waveform 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef58895 \" href=\"UTD.htm?14/39/14969\">",
"     waveform 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/5,9,10\">",
"     5,9,10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/62/42984?source=see_link\">",
"     \"Reentry and the development of cardiac arrhythmias\"",
"    </a>",
"    .) Less frequently, the retrograde limb uses another accessory AV pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/5,7,24,25\">",
"     5,7,24,25",
"    </a>",
"    ]. Mahaim fibers can also function as a bystander pathway, conducting an impulse antegradely during an AV nodal reentrant tachycardia, atrial flutter, or atrial tachycardia (",
"    <a class=\"graphic graphic_figure graphicRef61702 \" href=\"UTD.htm?16/35/16944\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef62450 \" href=\"UTD.htm?34/56/35722\">",
"     waveform 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef69146 \" href=\"UTD.htm?11/22/11625\">",
"     waveform 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/5,17\">",
"     5,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In Mahaim tachycardia, premature right atrial extrastimuli during tachycardia will usually result in preexcitation (advancement) of the next ventricular complex. This response of the tachycardia to premature atrial extrastimuli has been used by some investigators to suggest that the right atrium is an integral part of the tachycardia circuit and has been utilized in mapping of the atrial insertion of the accessory connection during catheter ablation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    AV dissociation during the tachycardia has also been described, a finding which would preclude the atria as part of the reentrant circuit [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/5\">",
"     5",
"    </a>",
"    ]. The variable pattern of atrial involvement in the tachycardia circuit suggests that there may be more than one anatomic substrate responsible for Mahaim fiber tachycardia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to other types of preexcitation syndromes, there are two treatment options available for treatment of Mahaim fiber tachycardias: pharmacologic therapy and curative ablation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the development of ablation techniques, empiric drug therapy was the preferred treatment of Mahaim tachycardia. Since this is an uncommon cause of tachycardia, there have been no large-scale comparative trials of different classes of drugs. The published data are limited to case reports and small studies demonstrating sensitivity to various classes of antiarrhythmic agents.",
"   </p>",
"   <p>",
"    Anterograde conduction in Mahaim tachycardia appears to be sensitive to adenosine but not to other agents that predominately affect the AV node, such as calcium blockers and beta blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/26\">",
"     26",
"    </a>",
"    ]. In some cases, however, the AV nodal blocking agents may be effective in preventing tachycardia by affecting retrograde AV nodal conduction in the retrograde limb of the tachycardia. Both class IA and IC agents also may slow or prevent tachycardia in patients with Mahaim fiber tachycardias [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Surgical ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presumed close relationship between the Mahaim fiber and normal AV nodal conduction tissue and the potential for complete AV nodal block with surgical intervention has resulted in little enthusiasm for operative therapy. However, the identification of right anterior accessory atrioventricular connections as the cause of most cases of Mahaim tachycardia has led to renewed interest in surgical division of the Mahaim fiber with preservation of normal AV nodal conduction. A number of small series have reported excellent results in symptomatic patients with these accessory AV connections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Catheter ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been several reports of direct current (DC) catheter ablation of the atrioventricular junction for treatment of recurrent tachycardia in patients with Mahaim fibers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In one series of three patients, ablation of the AV node interrupted an integral part of the tachycardia circuit [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/29\">",
"     29",
"    </a>",
"    ]. Despite the development of complete AV nodal block, there was preservation of antegrade Mahaim conduction, resulting in maximal ventricular preexcitation. These findings suggest that the Mahaim fibers in these cases were remote from the AV node rather than representing true nodofascicular fibers; the hypothesis is that most cases of Mahaim tachycardia are due to discrete atrioventricular pathways.",
"   </p>",
"   <p>",
"    In an attempt to ablate Mahaim fiber conduction with preservation of AV nodal conduction, one study of three patients with refractory Mahaim tachycardia performed DC catheter ablation at the site of presumed ventricular insertion of the Mahaim fiber [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/24\">",
"     24",
"    </a>",
"    ]. The ventricular insertion site was located using pace mapping, unipolar ventricular electrogram recordings, and identification of the earliest local electrogram relative to surface preexcited QRS. In all three cases, there was loss of Mahaim conduction without any change to AV nodal conduction parameters. Right bundle branch block persisted in two patients after ablation.",
"   </p>",
"   <p>",
"    Radiofrequency catheter ablation has been highly successful in the general treatment of accessory AV pathways, including right-sided atrioventricular accessory pathways with decremental properties [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17943/abstract/13,14,20-23\">",
"     13,14,20-23",
"    </a>",
"    ]. Detailed electrophysiologic assessment and mapping is required before considering radiofrequency ablation of patients with Mahaim fibers (",
"    <a class=\"graphic graphic_waveform graphicRef79320 \" href=\"UTD.htm?15/59/16308\">",
"     waveform 3",
"    </a>",
"    ). It is important to exclude additional accessory AV connections since their presence may influence the approach to ablation.",
"   </p>",
"   <p>",
"    Catheter ablation offers a definitive therapy for patients with right free wall decremental accessory pathways resulting in Mahaim tachycardia. The unique properties of these pathways pose some difficulties in the mapping of the insertion of the pathway and therefore the appropriate ablation site. Initial results suggest that mapping of the atrial insertion using the identification of a \"Mahaim potential\" is the best method to guide the site for ablation. Using this technique, a high success rate is possible with minimal morbidity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H177812\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac preexcitation describes premature activation of the ventricles via antegrade ventricular activation or retrograde atrial activation occurring partially or totally over an anomalous pathway distinct from the normal cardiac conduction system.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The classic form of cardiac preexcitation is the Wolff-Parkinson-White (WPW) pattern, characterized electrocardiographically by a short PR interval and a broad QRS complex with a delta wave. The anatomic substrate for this is a band of myocytes that bridges the fibrous atrioventricular (AV) junction, also known as the bundle of Kent. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mahaim fibers describe an accessory pathway with properties of decremental conduction (ie, conduction slows at faster heart rates), which only conducts in an antegrade fashion. Mahaim fibers most often arise in the anterior wall of the right atrium and insert into the right ventricle close to the right bundle branch. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Anatomic and functional features'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 40 percent of patients with Mahaim fibers have other accessory AV connections or dual AV nodal pathways. In addition, Mahaim fibers are also associated with Ebstein's anomaly of the tricuspid valve. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Conditions associated with Mahaim fibers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The resting electrocardiogram (ECG) in patients with Mahaim fibers is usually normal, due to preferential ventricular activation via the AV node at normal resting heart rates. In contrast to the WPW pattern, there is no delta wave with Mahaim fiber conduction.",
"     </li>",
"     <li>",
"      ECG features that are suggestive (but not diagnostic) of Mahaim fibers as the cause of a tachycardia with a left bundle branch block pattern (",
"      <a class=\"graphic graphic_waveform graphicRef56384 \" href=\"UTD.htm?25/45/26321\">",
"       waveform 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef58895 \" href=\"UTD.htm?14/39/14969\">",
"       waveform 2",
"      </a>",
"      ) include: QRS axis between 0 and minus 75 degrees, QRS duration of 0.15 seconds or less, R-wave in lead 1, rS complex in lead V1, precordial transition in lead V4 or later, and cycle length between 220 and 450 milliseconds (heart rates of 130 to 270 beats per minute). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Electrocardiographic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The two types of Mahaim pathways, atriofascicular and atrioventricular, can be distinguished by recording the site of earliest ventricular activation during tachycardia or maximal preexcitation. The most characteristic electrophysiologic feature of Mahaim fibers is their response to atrial pacing at progressively increasing rates (decremental atrial pacing). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Electrophysiology of Mahaim fibers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The usual arrhythmia in patients with a Mahaim fiber tachycardia is a reentrant tachycardia using the Mahaim fiber as the antegrade limb (since it only conducts in an antegrade fashion) and the AV node as the retrograde limb of the circuit (",
"      <a class=\"graphic graphic_figure graphicRef61702 \" href=\"UTD.htm?16/35/16944\">",
"       figure 3",
"      </a>",
"      ). Less frequently, the retrograde limb uses another accessory AV pathway. Mahaim fibers can also function as a bystander pathway, conducting an impulse antegradely during an AV nodal reentrant tachycardia, atrial flutter, or atrial tachycardia. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical arrhythmias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Similar to other types of preexcitation syndromes, there are two treatment options available for treatment of Mahaim fiber tachycardias: pharmacologic therapy and curative ablation. Since this is an uncommon cause of tachycardia, there have been no large-scale comparative trials of different classes of medications. Catheter ablation offers the greatest chance at definitive therapy for patients with decremental accessory pathways resulting in Mahaim tachycardia. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/1\">",
"      Anderson RH, Becker AE, Brechenmacher C, et al. Ventricular preexcitation. A proposed nomenclature for its substrates. Eur J Cardiol 1975; 3:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/2\">",
"      Mahaim, I, Benatt, A. Nouvelles recherches sur les connections superieures de la branche du faisceau de His-Tawara avec cloison interventriculaire. Cardiologia 1937; 1:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/3\">",
"      LEV M, LERNER R. The theory of Kent; a histologic study of the normal atrioventricular communications of the human heart. Circulation 1955; 12:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/4\">",
"      JAMES TN. Morphology of the human atrioventricular node, with remarks pertinent to its electrophysiology. Am Heart J 1961; 62:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/5\">",
"      Gallagher JJ, Smith WM, Kasell JH, et al. Role of Mahaim fibers in cardiac arrhythmias in man. Circulation 1981; 64:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/6\">",
"      Tonkin AM, Dugan FA, Svenson RH, et al. Coexistence of functional Kent and Mahaim-type tracts in the pre-excitation syndrome. Demonstration by catheter techniques and epicardial mapping. Circulation 1975; 52:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/7\">",
"      Ellenbogen KA, Ramirez NM, Packer DL, et al. Accessory nodoventricular (Mahaim) fibers: a clinical review. Pacing Clin Electrophysiol 1986; 9:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/8\">",
"      Bardy GH, Fedor JM, German LD, et al. Surface electrocardiographic clues suggesting presence of a nodofascicular Mahaim fiber. J Am Coll Cardiol 1984; 3:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/9\">",
"      Tchou P, Lehmann MH, Jazayeri M, Akhtar M. Atriofascicular connection or a nodoventricular Mahaim fiber? Electrophysiologic elucidation of the pathway and associated reentrant circuit. Circulation 1988; 77:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/10\">",
"      Klein GJ, Guiraudon GM, Kerr CR, et al. \"Nodoventricular\" accessory pathway: evidence for a distinct accessory atrioventricular pathway with atrioventricular node-like properties. J Am Coll Cardiol 1988; 11:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/11\">",
"      Murdock, C, Klein, GJ, Guiraudon, GM, et al. Epicardial mapping in patients with nodoventricular electrophysiologic pattern. Circulation 1990; 82(Suppl III):III-472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/12\">",
"      Gillette PC, Garson A Jr, Cooley DA, McNamara DG. Prolonged and decremental antegrade conduction properties in right anterior accessory connections: Wide QRS antidromic tachycardia of left bundle branch block pattern without Wolff-Parkinson-White configuration in sinus rhythm. Am Heart J 1982; 103:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/13\">",
"      Klein LS, Hackett FK, Zipes DP, Miles WM. Radiofrequency catheter ablation of Mahaim fibers at the tricuspid annulus. Circulation 1993; 87:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/14\">",
"      Ha&iuml;ssaguerre M, Cauchemez B, Marcus F, et al. Characteristics of the ventricular insertion sites of accessory pathways with anterograde decremental conduction properties. Circulation 1995; 91:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/15\">",
"      Jongbloed MR, Wijffels MC, Schalij MJ, et al. Development of the right ventricular inflow tract and moderator band: a possible morphological and functional explanation for Mahaim tachycardia. Circ Res 2005; 96:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/16\">",
"      Abbott JA, Scheinman MM, Morady F, et al. Coexistent Mahaim and Kent accessory connections: diagnostic and therapeutic implications. J Am Coll Cardiol 1987; 10:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/17\">",
"      Sung RJ, Styperek JL. Electrophysiologic identification of dual atrioventricular nodal pathway conduction in patients with reciprocating tachycardia using anomalous bypass tracts. Circulation 1979; 60:1464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/18\">",
"      Hamdan MH, Kalman JM, Lesh MD, et al. Narrow complex tachycardia with VA block: diagnostic and therapeutic implications. Pacing Clin Electrophysiol 1998; 21:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/19\">",
"      Sternick EB, Timmermans C, Sosa E, et al. The electrocardiogram during sinus rhythm and tachycardia in patients with Mahaim fibers: the importance of an \"rS\" pattern in lead III. J Am Coll Cardiol 2004; 44:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/20\">",
"      Okishige, K, Strickberger, SA, Walsh, EP, et al. Catheter ablation of the atrial origin of a decrementally conducting atriofascicular accessory pathway by radiofrequency current. J Cardiovasc Electrophysiol 1991; 2:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/21\">",
"      McClelland JH, Wang X, Beckman KJ, et al. Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials. Circulation 1994; 89:2655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/22\">",
"      Heald SC, Davies DW, Ward DE, et al. Radiofrequency catheter ablation of Mahaim tachycardia by targeting Mahaim potentials at the tricuspid annulus. Br Heart J 1995; 73:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/23\">",
"      Brugada J, Mart&iacute;nez-S&aacute;nchez J, Kuzmicic B, et al. Radiofrequency catheter ablation of atriofascicular accessory pathways guided by discrete electrical potentials recorded at the tricuspid annulus. Pacing Clin Electrophysiol 1995; 18:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/24\">",
"      Haissaguerre M, Warin JF, Le Metayer P, et al. Catheter ablation of Mahaim fibers with preservation of atrioventricular nodal conduction. Circulation 1990; 82:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/25\">",
"      Bardy GH, German LD, Packer DL, et al. Mechanism of tachycardia using a nodofascicular Mahaim fiber. Am J Cardiol 1984; 54:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/26\">",
"      Ellenbogen KA, Rogers R, Old W. Pharmacological characterization of conduction over a Mahaim fiber: evidence for adenosine sensitive conduction. Pacing Clin Electrophysiol 1989; 12:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/27\">",
"      Strasberg B, Coelho A, Palileo E, et al. Pharmacological observations in patients with nodoventricular pathways. Br Heart J 1984; 51:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/28\">",
"      Bhandari A, Morady F, Shen EN, et al. Catheter-induced His bundle ablation in a patient with reentrant tachycardia associated with a nodoventricular tract. J Am Coll Cardiol 1984; 4:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17943/abstract/29\">",
"      Ellenbogen KA, O'Callaghan WG, Colavita PG, et al. Catheter atrioventricular junction ablation for recurrent supraventricular tachycardia with nodoventricular fibers. Am J Cardiol 1985; 55:1227.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1001 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-221.10.40.232-E5FD8A8851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17943=[""].join("\n");
var outline_f17_33_17943=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H177812\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMIC AND FUNCTIONAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Conditions associated with Mahaim fibers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ELECTROCARDIOGRAPHIC FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ELECTROPHYSIOLOGY OF MAHAIM FIBERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Electrophysiologic mapping",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL ARRHYTHMIAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Surgical ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Catheter ablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H177812\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1001\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1001|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/5/23634\" title=\"figure 1\">",
"      Anatomy AV accessory pathways",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/58/35758\" title=\"figure 2\">",
"      Accessory paths in Mahaim tachy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/35/16944\" title=\"figure 3\">",
"      Mechanisms Mahaim tachy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1001|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?25/45/26321\" title=\"waveform 1\">",
"      Mahaim fiber tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?14/39/14969\" title=\"waveform 2\">",
"      AVNRT via Mahaim pathway",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?15/59/16308\" title=\"waveform 3\">",
"      Mahaim tachy RF ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?34/56/35722\" title=\"waveform 4\">",
"      AF via Mahaim pathway",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?11/22/11625\" title=\"waveform 5\">",
"      Mahaim tachy and AVNRT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39256?source=related_link\">",
"      Anatomy, pathophysiology and localization of accessory pathways in the preexcitation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39481?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17370?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of the Wolff-Parkinson-White syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11272?source=related_link\">",
"      Lown-Ganong-Levine syndrome and enhanced atrioventricular nodal conduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/62/42984?source=related_link\">",
"      Reentry and the development of cardiac arrhythmias",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_33_17944="The gifted child: Characteristics and identification";
var content_f17_33_17944=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The gifted child: Characteristics and identification",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17944/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17944/contributors\">",
"     L. Erik von Hahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17944/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17944/contributors\">",
"     Carolyn Bridgemohan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17944/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17944/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/33/17944/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H6676580\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gifted individuals have exceptional abilities in a particular domain or domains (eg, mathematics, music, athletics). In addition, they typically have high degrees of self-motivation, curiosity, perseverance, and enjoyment in developing and expressing their talents [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss the terminology, characteristics, and identification of gifted children. Educational interventions and primary care management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33240?source=see_link\">",
"     \"The gifted child: Educational interventions and primary care management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H370340910\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"   </p>",
"   <p>",
"    <strong>",
"     Giftedness",
"    </strong>",
"    &ndash; There is no universally accepted definition for giftedness, which can manifest in a variety of ways. However, there is broad consensus that giftedness cannot be defined solely by an intelligence quotient (IQ) score on a standardized test [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. IQ scores do not take into account creativity and practical intelligence.",
"   </p>",
"   <p>",
"    Other terms that are used to describe giftedness include &ldquo;outstanding talent&rdquo;, &ldquo;gifted and talented&rdquo;, and &ldquo;high-ability&rdquo;. (See",
"    <a class=\"local\" href=\"#H6676623\">",
"     'Presentation and characteristics'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H708855915\">",
"     'Identification'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The United States Department of Education (DOE) definition for giftedness is widely accepted by researchers and practitioners in the field of giftedness (",
"    <a class=\"graphic graphic_table graphicRef83643 \" href=\"UTD.htm?31/13/31963\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/3\">",
"     3",
"    </a>",
"    ]. The DOE definition is similar to that provided by the National Association for Gifted Children [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/4\">",
"     4",
"    </a>",
"    ]. In the United States, most state boards of education provide definitions for",
"    <span class=\"nowrap\">",
"     gifted/giftedness,",
"    </span>",
"    but the definitions may differ from the US DOE definition [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/5\">",
"     5",
"    </a>",
"    ]. The definitions used by individual states are available from the",
"    <a class=\"external\" href=\"file://www.nagc.org/GiftedByState.aspx\">",
"     National Association for Gifted Children",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    <strong>",
"     Gifts versus talents",
"    </strong>",
"    &ndash; &ldquo;Gifts&rdquo; and &ldquo;talents&rdquo; are two terms central to the discussion of giftedness. Some debate persists about the distinction between the terms. For the purpose of this topic review, we will use the following definitions [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gifts &ndash; Gifts are the skills or abilities that are innate to the individual. Giftedness does not become manifest unless the gift is developed.",
"     </li>",
"     <li>",
"      Talent &ndash; Talent is what the individual develops out of his or her gifts. Talents are the result of learning and experience. In this topic review, we use the term &ldquo;high ability&rdquo; interchangeably with &ldquo;talent&rdquo;.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <strong>",
"     School-house giftedness",
"    </strong>",
"    &ndash; School-house giftedness refers to intellectual or academic giftedness (eg, language, abstract logical thinking, mathematics).",
"   </p>",
"   <p>",
"    <strong>",
"     Nonschool-house giftedness",
"    </strong>",
"    &ndash; Nonschool-house giftedness refers to giftedness in non-intellectual domains (eg, music, art, dance, leadership).",
"   </p>",
"   <p>",
"    <strong>",
"     Twice-exceptional",
"    </strong>",
"    &ndash; Twice-exceptional is the term used by practitioners in the field of giftedness to describe children with coexisting giftedness and neurodevelopmental or psychiatric conditions (eg, giftedness and learning disability) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6676623\">",
"    <span class=\"h1\">",
"     PRESENTATION AND CHARACTERISTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The parent of a gifted child may present to the primary care physician describing characteristics associated with giftedness (",
"    <a class=\"graphic graphic_table graphicRef83641 \" href=\"UTD.htm?24/11/24764\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/8-12\">",
"     8-12",
"    </a>",
"    ]. Gifted children typically have high degrees of self-motivation, curiosity, perseverance, and enjoyment in developing and expressing their talents [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Children with giftedness also may present with problems at school that the parent attributes to being insufficiently challenged (eg, boredom, inattention, distracting other students, underachievement) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/13\">",
"     13",
"    </a>",
"    ]. Gifted children may underachieve at school for a variety of reasons (eg, fear of failure, desire to fit in with peers, anti-intellectual school atmosphere, poor study habits, coexisting learning disability, and frustration due to boredom) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10,14,15\">",
"     10,14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H559401950\">",
"    <span class=\"h2\">",
"     Developmental characteristics",
"    </span>",
"   </p>",
"   <p>",
"    <strong>",
"     Advanced domain-general skills and capacity for learning rapidly &ndash;",
"    </strong>",
"    Gifted children may have obviously advanced skills in language, reasoning, or humor (",
"    <a class=\"graphic graphic_table graphicRef83641 \" href=\"UTD.htm?24/11/24764\">",
"     table 2",
"    </a>",
"    ). They may develop their skills quickly and be able to rapidly and intuitively understand concepts or make connections between one concept and another. Young children may have conversational skills and interests more commonly seen in older children and may prefer the company of older children. Older children may acquire academic skills quickly and complain of boredom at school.",
"   </p>",
"   <p>",
"    <strong>",
"     Developmental asynchrony",
"    </strong>",
"    &ndash; Gifted children may be very advanced in some areas, but have average or below average skills in others. Parents may state, for example, that the child has highly advanced mechanical skills, math skills, or reasoning skills, but age-appropriate or even delayed handwriting or reading skills.",
"   </p>",
"   <p>",
"    Gifted children also may have different rates of intellectual, social, and emotional development. As an example, a 4-year-old child may have the intellectual skills (eg, thinking, writing, mathematical) of an 8-year-old, but age-appropriate social and emotional development [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10\">",
"     10",
"    </a>",
"    ]. Developmental asynchrony may lead to difficulty finding playmates or may result in expectations of behavioral or social maturity beyond the child&rsquo;s capacity. Both of these situations can lead to frustration and experiences of disappointment.",
"   </p>",
"   <p>",
"    The series of writing samples from a child in a gifted kindergarten class (",
"    <a class=\"graphic graphic_figure graphicRef83647 graphicRef83648 graphicRef83649 graphicRef83650 \" href=\"UTD.htm?41/62/42986\">",
"     figure 1A-D",
"    </a>",
"    ) demonstrates some of these characteristics:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Advanced skills &ndash; The student&rsquo;s advanced writing skills are present before kindergarten. The sample from the beginning of the year (",
"      <a class=\"graphic graphic_figure graphicRef83647 \" href=\"UTD.htm?23/59/24500\">",
"       figure 1A",
"      </a>",
"      ) reveals late kindergarten or early grade one writing skills.",
"     </li>",
"     <li>",
"      Rapid pace of learning &ndash; The rate of improvement in writing far surpasses what would be expected of a typical kindergarten student. The final writing sample (",
"      <a class=\"graphic graphic_figure graphicRef83650 \" href=\"UTD.htm?37/17/38166\">",
"       figure 1D",
"      </a>",
"      ) is much more sophisticated in text and word complexity than the initial writing sample; it is more characteristic of a grade three (ie, 8- to 9-year-old) student than a student finishing kindergarten. However, spelling skills are more characteristic of a grade two (ie, 7- to 8-year-old) student.",
"     </li>",
"     <li>",
"      Handwriting skills &ndash; This student&rsquo;s handwriting skills improve over the course of the year. However, some gifted students may not have the same rate of improvement in handwriting skills as they do in cognitive skills, resulting in developmental asynchrony.",
"     </li>",
"     <li>",
"      Drawing skills &ndash; The student&rsquo;s drawing skills are age-appropriate, and are not advanced.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H559401957\">",
"    <span class=\"h2\">",
"     Emotional characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gifted children generally have good emotional adjustment [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/16\">",
"     16",
"    </a>",
"    ]. In observational studies, children with school-house giftedness in the moderate range typically have slightly lower rates of emotional difficulty than those in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. However, the rate of social-emotional problems among profoundly gifted children (ie, those with intelligence quotient &gt;160) is about twice as high as in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. The social and emotional adjustment problems of profoundly gifted students appear to be related to difficulty finding a peer group and appropriate academic stimulation.",
"   </p>",
"   <p>",
"    Although gifted children generally are well adjusted emotionally, they have particular areas of emotional vulnerability, including [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10,13,20,21\">",
"     10,13,20,21",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      They may be extremely perfectionistic and have difficulty accepting failure. This can lead to anxiety and avoidance behaviors. Perfectionism can be debilitating, especially if the child is excessively self-critical and unable to celebrate his or her accomplishments, or is motivated by fear of failure or the desire to please others.",
"     </li>",
"     <li>",
"      They may experience their emotions strongly and react to situations that are unnoticed or evoke only mild reactions in age-matched peers (eg, an 8- or 9-year-old child who is saddened by world poverty). They may be more sensitive to criticism and injustice than age-matched peers.",
"     </li>",
"     <li>",
"      They may be moody, explosive, argumentative, or defiant when they cannot reach their goal or when they cannot continue to pursue their area of interest. They may become depressed by their limited ability to attain what others perceive as overly idealistic goals.",
"     </li>",
"     <li>",
"      They may become frustrated by the inconsistent behavior of others.",
"     </li>",
"     <li>",
"      They may be socially isolated, feeling &ldquo;different&rdquo; than other children and believing that age-matched peers think differently and about different things than those that interest them; profoundly gifted students are at the greatest risk of social isolation because of the extreme asynchrony between their intellectual development and their emotional and social development.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H559401965\">",
"    <span class=\"h2\">",
"     Social characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Social characteristics of gifted children may include [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/8-12,14\">",
"     8-12,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tendency to be solitary and introverted; they enjoy playing on their own and pursuing their own interests",
"     </li>",
"     <li>",
"      Lack of interest in socializing with peers of the same age; may seek out older peers with whom to socialize",
"     </li>",
"     <li>",
"      Highly focused on their own agenda and goals; may be considered &ldquo;narcissistic&rdquo;",
"     </li>",
"     <li>",
"      Greatly concerned with moral and philosophical questions (eg, becoming easily upset when faced with problems of injustice or situations that are perceived as unfair in response to social interactions with peers or larger societal concerns)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H559401973\">",
"    <span class=\"h2\">",
"     Behavioral characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Behavioral characteristics of gifted children may include [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/8-12\">",
"     8-12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Disorganization or inattentiveness (partly because they are preoccupied by their area of interest)",
"     </li>",
"     <li>",
"      Constantly asking questions about their area of interest",
"     </li>",
"     <li>",
"      Overly focusing on their area of expertise (to the point of preferring solitary activities to socializing)",
"     </li>",
"     <li>",
"      Fierce independence and nonconforming",
"     </li>",
"     <li>",
"      Interest in experimenting and doing things differently or putting ideas or things together in ways that are unusual or creative; this behavior is not always valued in the home or classroom setting",
"     </li>",
"     <li>",
"      Intense bursts of",
"      <span class=\"nowrap\">",
"       effort/work",
"      </span>",
"      for one or several hours, followed by a period of not being able to engage in that activity at all and being tired and listless",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H119666389\">",
"    <span class=\"h1\">",
"     COEXISTING CONDITIONS AND DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Students who are gifted may have coexisting conditions such as learning disability (LD), attention deficit hyperactivity disorder (ADHD) or other behavior disorders, autism, anxiety, or depression [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/12\">",
"     12",
"    </a>",
"    ]. In such cases, it can be difficult to identify both the giftedness and the coexisting condition&mdash;giftedness can be &ldquo;masked&rdquo; or overshadowed by the other condition and vice versa [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Children with coexisting giftedness and other neurodevelopmental conditions may be referred to as &ldquo;twice exceptional&rdquo;. (See",
"    <a class=\"local\" href=\"#H370340910\">",
"     'Terminology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    It is important to differentiate between features of giftedness that mimic other conditions (eg, inattention), and twice exceptionality so that appropriate services can be provided. Professional evaluation, including comprehensive psychological or neuropsychological evaluation, may be necessary for accurate diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H708855915\">",
"     'Identification'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33240?source=see_link\">",
"     \"The gifted child: Educational interventions and primary care management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H710039047\">",
"    <span class=\"h2\">",
"     Learning disability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Students who are gifted can have a coexistent LD. The developmental asynchrony between the student&rsquo;s strengths and weakness may need to be quite marked for both conditions to be identified. In some cases, a parent or teacher may focus on delays or difficulties in one area (eg, handwriting, phoneme awareness) and overlook indications of giftedness in other areas (eg, mathematics) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/7\">",
"     7",
"    </a>",
"    ]. In other cases, parents or teachers may overlook learning difficulties in a gifted child because they assume that the child&rsquo;s giftedness will compensate for the difficulties [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Identification of a coexistent LD may be facilitated by using an assessment procedure that compares the gifted student&rsquo;s achievement with",
"    <span class=\"nowrap\">",
"     his/her",
"    </span>",
"    intellectual potential rather than the intellectual performance of same-age or same-grade peers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/57/32665?source=see_link\">",
"     \"Specific learning disabilities in children: Clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/6/35944?source=see_link\">",
"     \"Specific learning disabilities in children: Evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the LD is not detected",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    addressed, the gifted student may be discouraged by lack of achievement or lower achievement in the area of weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10\">",
"     10",
"    </a>",
"    ]. He or she may lose confidence and enthusiasm for school.",
"   </p>",
"   <p>",
"    Educational interventions and strategies for gifted students who also have a LD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33240?source=see_link&amp;anchor=H184753969#H184753969\">",
"     \"The gifted child: Educational interventions and primary care management\", section on 'Gifted with learning disability'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37306?source=see_link\">",
"     \"Specific learning disabilities in children: Educational management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6676837\">",
"    <span class=\"h2\">",
"     ADHD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Students who are gifted can have coexistent ADHD (ie, intrinsic difficulty regulating attention) (",
"    <a class=\"graphic graphic_table graphicRef50326 \" href=\"UTD.htm?11/27/11709\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10\">",
"     10",
"    </a>",
"    ]. However, they also may appear to be inattentive or disorganized because they are bored or preoccupied with their area of interest.",
"   </p>",
"   <p>",
"    It is important to determine whether symptoms of inattention in a gifted child are a manifestation of his or her giftedness or coexisting ADHD. Children with coexistent ADHD may require treatment with medication",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    behavioral therapies in addition to the educational interventions and strategies for giftedness. In contrast, inattention due to boredom or preoccupation with an area of interest is treated by offering an appropriate level of stimulation.",
"   </p>",
"   <p>",
"    Whereas inattention due to boredom is purposeful and is recognized by the student if he or she is asked for an explanation, most students with ADHD are not able to explain their inattention [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/27\">",
"     27",
"    </a>",
"    ]. In addition, the symptoms of inattention",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hyperactivity in ADHD must occur in more than one setting and affect the student&rsquo;s ability to function at school, home, or in community activities (",
"    <a class=\"graphic graphic_table graphicRef50326 \" href=\"UTD.htm?11/27/11709\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/18/26922?source=see_link&amp;anchor=H830607507#H830607507\">",
"     \"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When gifted students are provided with an appropriate level of stimulation, inattention and other inappropriate behaviors may diminish. However, most children with ADHD require behavioral",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical treatments to circumvent their inattention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/61/32730?source=see_link&amp;anchor=H268239#H268239\">",
"     \"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis\", section on 'Overview of management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6676212\">",
"    <span class=\"h2\">",
"     Behavior disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Students who are gifted can have coexisting behavior disorders (eg, intrinsic difficulty regulating their expression of anger, accepting demands from adults, and conforming to routine standards of conduct). However, giftedness can mimic psychiatric conditions, and the behaviors of gifted children may be similar to those of children with true behavior disorders.",
"   </p>",
"   <p>",
"    Intrinsic difficulty with self-regulation must be distinguished from challenging behaviors related to giftedness (eg, the creative ways in which gifted children explore their interests or solve problems; incessant questions; frustration when not permitted to pursue their interests or when their performance does not live up to their perfectionistic standards).",
"   </p>",
"   <p>",
"    The diagnostician",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    therapist who works with gifted children should understand aspects of giftedness that can mimic psychiatric conditions such as &ldquo;narcissism&rdquo;. To meet criteria for a behavior disorder, the behavior problems must be frequent, severe, and pervasive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6676219\">",
"    <span class=\"h2\">",
"     Autism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Students who are gifted can have a coexisting autism spectrum disorder (ASD) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/23\">",
"     23",
"    </a>",
"    ]. However, the over-focus on preferred interests and the social isolation that can ensue in gifted children also can be mistaken for an ASD.",
"   </p>",
"   <p>",
"    It is important to differentiate between ASD, features of giftedness that mimic ASD, and coexistent giftedness and ASD so that appropriate services can be provided. In contrast to individuals with ASD, most gifted students are able to explain why they choose to pursue certain interests, and why they may choose to limit their social interactions. The intense interests of gifted children are functional, varied, and can lead to a vocation. In addition, most gifted students enjoy social interactions, although they may be selective about the peers with whom they socialize.",
"   </p>",
"   <p>",
"    A true lack of interest in social activities, or over-focus on an excessively narrow range of interests, may be more compatible with an ASD. In children with ASD, the severity of social impairment results in functional impairments at school, home, or in the community (",
"    <a class=\"graphic graphic_table graphicRef72403 \" href=\"UTD.htm?29/6/29804\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/41/664?source=see_link\">",
"     \"Clinical features of autism spectrum disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=see_link\">",
"     \"Diagnosis of autism spectrum disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The identification of coexistent giftedness and ASD may require referral for comprehensive neurodevelopmental, psychological, or neuropsychological evaluation by a developmental-behavioral pediatrician, a child psychiatrist, or neuropsychologist who can identify both the giftedness and the disability [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. In contrast to gifted students without a coexisting condition, gifted students with coexistent ASD may [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Have a pedantic and seamless speech pattern",
"     </li>",
"     <li>",
"      Have little tolerance for change",
"     </li>",
"     <li>",
"      Not understand socially reciprocal humor",
"     </li>",
"     <li>",
"      Have motor clumsiness",
"     </li>",
"     <li>",
"      Have an inappropriate affect",
"     </li>",
"     <li>",
"      Lack insight regarding social relationships and emotions",
"     </li>",
"     <li>",
"      Have stereotyped behaviors",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6676233\">",
"    <span class=\"h2\">",
"     Anxiety or depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gifted students can have anxiety or depression related to understimulation of their giftedness, lack of social stimulation, or as a coexistent condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=see_link\">",
"     \"Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H708855915\">",
"    <span class=\"h1\">",
"     IDENTIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Giftedness usually is formally identified by neuropsychologists, school psychologists, or experts in the child&rsquo;s area of talent. The way in which giftedness is identified may vary depending upon the circumstances. Formal identification of giftedness may be important to determine eligibility for certain education programs, services, or special consideration.",
"   </p>",
"   <p>",
"    The identification of giftedness is to some extent culturally determined. The recognition of intelligence, academic success, and talents in nonacademic domains depends upon what types of skills are valued in a given community, and what types of skills are valued or fostered by the family. Because these values are different in different communities and cultures, children from certain cultural or linguistic backgrounds may be underrepresented in programs for school-house giftedness, particularly if it is identified by intelligence quotient (IQ) score alone [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12720745\">",
"     'Pitfalls in identification'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H708855937\">",
"    <span class=\"h2\">",
"     School-house giftedness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neither the United States Department of Education (DOE) definition of",
"    <span class=\"nowrap\">",
"     giftedness/high",
"    </span>",
"    ability nor other definitions of giftedness provide guidance for identification of school-house (ie, intellectual or academic) giftedness (",
"    <a class=\"graphic graphic_table graphicRef83643 \" href=\"UTD.htm?31/13/31963\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    School-house giftedness generally is identified through a combination of intelligence testing and qualitative measures [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/24\">",
"     24",
"    </a>",
"    ]. In the final determination, the informed judgment of educators and psychologists is more important than strict cut-off scores. The reliability and validity of identification is increased by including multiple measures, criteria, and sources of information [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H131016359\">",
"    <span class=\"h3\">",
"     Intelligence quotient",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple measures are needed to successfully identify intellectual giftedness [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/2\">",
"     2",
"    </a>",
"    ]. However, the IQ is a central feature of most identification practices. Verbal, analytic, and logical thinking skills, which are measured by intelligence testing, are necessary for school-house giftedness, but they are not the only skills needed for academic success. Measures of creativity and practical intelligence have been created, but their reliability and validity are not yet documented [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Different cut-off IQ scores are used to identify giftedness in different circumstances. Historically, the 99",
"    <sup>",
"     th",
"    </sup>",
"    percentile (an IQ score of 130 or higher) is used as part of the definition of intellectual giftedness [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/30\">",
"     30",
"    </a>",
"    ]. A more nuanced set of definitions is based upon different ranges of IQ scores. As an example [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mildly gifted &ndash; Full scale IQ 115 to 129 (top 2.5 percent); the capacity for learning, social qualities, or other areas of talent may be used to identify a student with IQ in this range as gifted",
"     </li>",
"     <li>",
"      Moderately gifted &ndash; Full scale IQ 130 to 144 (top 1 percent)",
"     </li>",
"     <li>",
"      Highly gifted IQ &ndash; Full scale IQ 145 to 159 (top 0.13 percent)",
"     </li>",
"     <li>",
"      Intelligence measures can be inaccurate when the IQ score is &gt;160; children with IQ in this range are described as exceptionally or profoundly gifted (top 0.003 percent and beyond)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A definition based on IQ score alone is reliable (ie, repeated measurements fall closely together), but subject to limitations [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/30,32,33\">",
"     30,32,33",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Relying exclusively on IQ score may fail to identify gifted students because of measurement error, minority cultural or linguistic status, or poor performance by the student on the day of the test",
"     </li>",
"     <li>",
"      IQ scores are not appropriate for use in some populations (eg, children from socio-linguistic backgrounds different than those of the children on whom the test was standardized, young children, children with learning disabilities)",
"     </li>",
"     <li>",
"      Some IQ measures have upper boundaries that limit their usefulness in the identification of giftedness (ie, &gt;130)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Limitations of psychometric measures are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/6/35944?source=see_link&amp;anchor=H24#H24\">",
"     \"Specific learning disabilities in children: Evaluation\", section on 'Limitations of psychometric measures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite their limitations, standardized tests of intelligence can be helpful when there are specific issues to address (eg, eligibility early school entry or entry into a special program; helping to determine whether boredom or misbehavior in the classroom is due to understimulation or learning disability) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H119666389\">",
"     'Coexisting conditions and differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H131016388\">",
"    <span class=\"h3\">",
"     Qualitative measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Qualitative measures that can be used in the identification of giftedness include the student&rsquo;s educational history, work samples, report cards, portfolios, teacher nominations, and peer nominations [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12720745\">",
"    <span class=\"h3\">",
"     Pitfalls in identification",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pitfalls in the identification of giftedness may include the following: [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/7,9,10,13,34\">",
"     7,9,10,13,34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some children may not be willing to display their abilities in front of clinicians or teachers, whether because of cultural differences and what is considered to be appropriate behavior towards adults, or because of peer pressure, etc.",
"     </li>",
"     <li>",
"      Language barriers may mask curiosity or may limit the student&rsquo;s capacity to express what",
"      <span class=\"nowrap\">",
"       s/he",
"      </span>",
"      knows.",
"     </li>",
"     <li>",
"      Adults may attribute characteristics of giftedness to other conditions (eg, inattentiveness may be attributed to attention deficit hyperactivity disorder rather than to boredom from understimulation; questioning the teacher or parent may be attributed to oppositional defiant disorder rather than to curiosity). (See",
"      <a class=\"local\" href=\"#H119666389\">",
"       'Coexisting conditions and differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The gift is masked by a learning disability (decreased performance in the weak area may lower the overall IQ score). (See",
"      <a class=\"local\" href=\"#H119666389\">",
"       'Coexisting conditions and differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Giftedness may be overshadowed by a psychiatric condition (eg, depression anxiety).",
"     </li>",
"     <li>",
"      Adults may not recognize underachievement as a clue to giftedness (eg, if the student is bored, has low self-esteem, or a fear of failure).",
"     </li>",
"     <li>",
"      The child&rsquo;s may &ldquo;hide&rdquo; his or her intellectual ability to appear more like his or her peers.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H131016510\">",
"    <span class=\"h2\">",
"     Nonschool-house giftedness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Giftedness in nonacademic domains (eg, music, art, athletics, leadership) is usually identified by experts in the field, review of work samples, and performance history [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/29\">",
"     29",
"    </a>",
"    ]. Psychometrically sound instruments to assess nonacademic giftedness are lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H708854550\">",
"    <span class=\"h1\">",
"     ROLE OF THE PRIMARY CARE PROVIDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary care provider may play a role in identifying giftedness and coexisting conditions and providing anticipatory guidance and support to families with a gifted child [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/24\">",
"     24",
"    </a>",
"    ]. This section will focus on the role of the primary care provider in identification of giftedness and coexisting conditions. The support role of the primary care provider is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33240?source=see_link&amp;anchor=H184753990#H184753990\">",
"     \"The gifted child: Educational interventions and primary care management\", section on 'Role of the primary care provider'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The primary care provider may identify potential giftedness in early development through routine developmental surveillance [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10,24\">",
"     10,24",
"    </a>",
"    ]. Advanced verbal skills are easiest to identify; other clues to advanced abilities may include self-directed interests in projects or increased depth and breadth in an academic or non-academic domain, as compared to similarly aged children (",
"    <a class=\"graphic graphic_table graphicRef83641 \" href=\"UTD.htm?24/11/24764\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the school-age child, the primary care provider may recognize giftedness as a possible cause of underachievement, inattention, behavior disturbances, or atypical social behaviors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H119666389\">",
"     'Coexisting conditions and differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Once potential giftedness is identified, the primary care provider can help with referrals for more definitive evaluation (ie, comprehensive psychoeducational or neuropsychological evaluation) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17944/abstract/10,24\">",
"     10,24",
"    </a>",
"    ]. When making such referrals it is important to ensure that the tester has experience with gifted children. (See",
"    <a class=\"local\" href=\"#H708855937\">",
"     'School-house giftedness'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6676262\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resources for clinicians and families are provided in the Table (",
"    <a class=\"graphic graphic_table graphicRef83644 \" href=\"UTD.htm?19/16/19725\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H466903144\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gifted individuals have exceptional abilities in a particular domain or domains (eg, mathematics, music, athletics). There is no universally accepted definition for giftedness. However, the United States Department of Education definition for giftedness (",
"      <a class=\"graphic graphic_table graphicRef83643 \" href=\"UTD.htm?31/13/31963\">",
"       table 1",
"      </a>",
"      ) is the widely accepted by researchers and practitioners in the field of giftedness. (See",
"      <a class=\"local\" href=\"#H6676580\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H370340910\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The parent(s) of a gifted child may present to the primary care physician describing characteristics associated with giftedness (",
"      <a class=\"graphic graphic_table graphicRef83641 \" href=\"UTD.htm?24/11/24764\">",
"       table 2",
"      </a>",
"      ). Gifted children also may present with problems at school that the parent attributes to being insufficiently challenged (eg, boredom, inattention, distracting other students, underachievement). (See",
"      <a class=\"local\" href=\"#H6676623\">",
"       'Presentation and characteristics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gifted children may be very advanced in some areas, but have average or below average skills in others. They generally have good emotional adjustment, but they have particular areas of emotional vulnerability (eg, perfectionism, intense emotions, social isolation). They tend to be introverted and enjoy playing on their own. They can be highly focused on their own areas of interest. (See",
"      <a class=\"local\" href=\"#H6676623\">",
"       'Presentation and characteristics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Students who are gifted may have coexisting conditions such as learning disability, attention deficit hyperactivity disorder (ADHD) or other behavior disorders, autism, anxiety, or depression. In such cases, it can be difficult to identify both the giftedness and the coexisting condition. Gifted children also may have symptoms of these conditions that are a manifestation of their giftedness (eg, inattention due to boredom or preoccupation with an area of interest rather than ADHD). Professional evaluation, including comprehensive psychological or neuropsychological evaluation, may be necessary for accurate diagnosis. (See",
"      <a class=\"local\" href=\"#H119666389\">",
"       'Coexisting conditions and differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Giftedness usually is formally identified by neuropsychologists, school psychologists, or experts in the child&rsquo;s area of talent. School-house giftedness generally is identified through a combination of intelligence testing and qualitative measures (eg, educational history, work samples, report cards, portfolios, etc). (See",
"      <a class=\"local\" href=\"#H708855915\">",
"       'Identification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The primary care provider may identify potential giftedness through routine developmental surveillance (",
"      <a class=\"graphic graphic_table graphicRef83641 \" href=\"UTD.htm?24/11/24764\">",
"       table 2",
"      </a>",
"      ) or by recognizing giftedness as a possible cause of underachievement, inattention, behavior disturbances, or atypical social behaviors. Once potential giftedness is recognized, the primary care provider can make referrals for formal identification (eg, to a neuropsychologist, school psychologist) or for evaluation and management of a coexisting condition. (See",
"      <a class=\"local\" href=\"#H708854550\">",
"       'Role of the primary care provider'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6676948\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author wishes to acknowledge James T Webb, PhD (founder of Supporting Emotional Needs of the Gifted [SENG] and former professor and associate Dean, School of Professional Psychology, Wright State University, Dayton, OH) and Marianne Kuzujanakis, MD (Director, SENG) for their valuable contributions to this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/1\">",
"      Landesman S. Defining giftedness. Pediatr Ann 1985; 14:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/2\">",
"      Volker MA, Lopata C, Cook-Cottone C. Assessment of children with intellectual giftedness and reading disabilities. Psychol Sch 2006; 43:855.",
"     </a>",
"    </li>",
"    <li>",
"     National Excellence: A case for developing America's talent. 1993. file://www.eric.ed.gov/PDFS/ED359743.pdf (Accessed on May 08, 2012).",
"    </li>",
"    <li>",
"     National Association for Gifted Children Position Paper: Redefining Giftedness for a New Century: Shifting the Paradigm. March 2010. Available at: www.nagc.org/index2.aspx?id=6404 (Accessed on May 09, 2012).",
"    </li>",
"    <li>",
"     National Association for Gifted Children. Gifted in the States. file://www.nagc.org/GiftedByState.aspx (Accessed on May 08, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/6\">",
"      Gagn&eacute; F. Transforming gifts into talents: The DMGT as a developmental theory. High Ability Studies 2004; 15:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/7\">",
"      Pfeiffer SI. The gifted: clinical challenges for child psychiatry. J Am Acad Child Adolesc Psychiatry 2009; 48:787.",
"     </a>",
"    </li>",
"    <li>",
"     Winner E. Gifted Children: Myths and Realities, Basic Books, New York 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/9\">",
"      Winner E. Exceptionally high intelligence and schooling. Am Psychol 1997; 52:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/10\">",
"      Robinson NM, Olszewski-Kubilius PM. Gifted and talented children: issues for pediatricians. Pediatr Rev 1996; 17:427.",
"     </a>",
"    </li>",
"    <li>",
"     Ruf DL. 5 Levels of Gifted: School Issues and Educational Options, Great Potential Press, Scottsdale, AZ 2009.",
"    </li>",
"    <li>",
"     Webb TJ, Amend ER, Webb NE, et al. Misdiagnosis and Dual Diagnosis of Gifted Children and Adults: ADHD, Bipolar, OCD, Asperger&rsquo;s, Depression, and Other Disorders, Great Potential Press, Scottsdale, AZ 2005.",
"    </li>",
"    <li>",
"     Rock M. The gifted child. In: The Zuckerman Parker Handbook of Developmental and Behavioral Pediatrics for Primary Care, 3rd, Augustyn MA, Zuckerman B, Caronna EB.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. p.234.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/14\">",
"      Liu YH, Lien J, Kafka T, Stein MT. Discovering gifted children in pediatric practice. J Dev Behav Pediatr 2005; 26:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/15\">",
"      Hoover-Schultz B. Gifted underachievement: oxymoron or educational enigma? Gifted Child Today 2005; 28:46.",
"     </a>",
"    </li>",
"    <li>",
"     The social and emotional development of gifted chidlren. What do we know?, Neihart M, Reis S, Robinson N, Moon SM.  (Eds), Prufrock Press, Waco, TX 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/17\">",
"      Reis SM, Renzulli JS. Current research on the social and emotional development of gifted and talented students: Good news and future possibilities. Psychol Sch 2004; 41:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/18\">",
"      Neihart M. The impact of giftedness on psychological well-being. Roeper Rev 1999; 22:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/19\">",
"      Robinson A, Clinkenbeard PR. Giftedness: an exceptionality examined. Annu Rev Psychol 1998; 49:117.",
"     </a>",
"    </li>",
"    <li>",
"     Webb J. Dabrowski&rsquo;s Theory and Existential Depression in Gifted Children and Adults. 2009 Davidson Institute for Talent Development. Available at: www.davidsongifted.org/db/Articles_id_10554.aspx (Accessed on May 08, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/21\">",
"      Schuler PA. Perfectionism and the gifted adolescent. J Secondary Gifted Educ 2000; 11:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/22\">",
"      Assouline SG, Nipcon MF, Whitman C. Cognitive and psychosocial characteristics of gifted students with written language disability. Gift Child Q 2010; 54:102.",
"     </a>",
"    </li>",
"    <li>",
"     Neihart M. Gifted children with Asperger&rsquo;s Syndrome. Gift Child Q 2000; 44:222. Available at: www.davidsongifted.org/db/Articles_id_10167.aspx (Accessed on May 08, 2012).",
"    </li>",
"    <li>",
"     Kral MC. The gifted child. In: Developmental-Behavioral Pediatrics, Carey WB, Crocker AC, Coleman WL, et al.  (Eds), Saunders-Elsevier, Philadelphia 2009. p.506.",
"    </li>",
"    <li>",
"     National Association for Gifted Children. Common Gifted Education Myths. Available at: www.nagc.org/commonmyths.aspx (Accessed on May 08, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/26\">",
"      Lovett BJ, Lewandowski LJ. Gifted students with learning disabilities: Who are they? J Learn Disabil 2006; 36:515.",
"     </a>",
"    </li>",
"    <li>",
"     Lind S. Before referring a gifted child for ADD/ADHD evaluation. 1996. file://www.sengifted.org/archives/articles/before-referring-a-gifted-child-for-addadhd-evaluation (Accessed on May 08, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/28\">",
"      Ford DY, Grantham TC, Whiting GW. Culturally and linguistically diverse students in gifted education: Recruitment and retention issues. Except Child 2008; 74:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/29\">",
"      Pfeiffer SI. Professional psychology and the gifted: Emerging practice opportunities. Prof Psychol Res Pr 2001; 32:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/30\">",
"      McCoach DB, Kehle TJ, Bray MA, Siegle D. Best Practices in the Identification of Gifted Students with Learning Disabilities. Psychol Sch 2001; 38:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/31\">",
"      Mandelman SD, Tan M, Aljughaiman AM, Grigorenko EL. Intellectual giftedness: Economic, political, cultural, and psychological considerations. Learning and Individual Differences 2010; 20:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/32\">",
"      Ford D. Culturally and linguistically diverse students in gifted education: recruitment and retention issues. Exceptional Children 2008; 74:289.",
"     </a>",
"    </li>",
"    <li>",
"     Webb JT, Kleine PA. Assessing gifted and talented children. In: Testing Young Children: A Reference Guide for Developmental, Psychoeducational, and Psychosocial Assessments, Culbertson JL, Willis DJ (Eds), PRO-ED, Austin, TX 1993. p.383.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17944/abstract/34\">",
"      Feiring C, Taft LT. The gifted learning disabled child: not a paradox. Pediatr Ann 1985; 14:729.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14351 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-D8D1174216-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17944=[""].join("\n");
var outline_f17_33_17944=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H466903144\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6676580\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H370340910\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6676623\">",
"      PRESENTATION AND CHARACTERISTICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H559401950\">",
"      Developmental characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H559401957\">",
"      Emotional characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H559401965\">",
"      Social characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H559401973\">",
"      Behavioral characteristics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H119666389\">",
"      COEXISTING CONDITIONS AND DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H710039047\">",
"      Learning disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6676837\">",
"      ADHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6676212\">",
"      Behavior disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6676219\">",
"      Autism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6676233\">",
"      Anxiety or depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H708855915\">",
"      IDENTIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H708855937\">",
"      School-house giftedness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H131016359\">",
"      - Intelligence quotient",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H131016388\">",
"      - Qualitative measures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12720745\">",
"      - Pitfalls in identification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H131016510\">",
"      Nonschool-house giftedness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H708854550\">",
"      ROLE OF THE PRIMARY CARE PROVIDER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6676262\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H466903144\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6676948\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/14351\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14351|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/59/24500\" title=\"figure 1A\">",
"      Gifted writing sample 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/57/29590\" title=\"figure 1B\">",
"      Gifted writing sample 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/26/2470\" title=\"figure 1C\">",
"      Gifted writing sample 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/17/38166\" title=\"figure 1D\">",
"      Gifted writing sample 4",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14351|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/13/31963\" title=\"table 1\">",
"      Giftedness definitions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/11/24764\" title=\"table 2\">",
"      Giftedness characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/27/11709\" title=\"table 3\">",
"      DSM-IV-TR criteria for ADHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/6/29804\" title=\"table 4\">",
"      DSM IV criteria autism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/16/19725\" title=\"table 5\">",
"      Giftedness resources",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/18/26922?source=related_link\">",
"      Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/61/32730?source=related_link\">",
"      Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/41/664?source=related_link\">",
"      Clinical features of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=related_link\">",
"      Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=related_link\">",
"      Diagnosis of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/57/32665?source=related_link\">",
"      Specific learning disabilities in children: Clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/27/37306?source=related_link\">",
"      Specific learning disabilities in children: Educational management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/6/35944?source=related_link\">",
"      Specific learning disabilities in children: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33240?source=related_link\">",
"      The gifted child: Educational interventions and primary care management",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_33_17945="Discoid lupus - right cheek";
var content_f17_33_17945=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F64844%7EDERM%2F75833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F64844%7EDERM%2F75833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Discoid lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Well-defined, erythematous plaques with scale are present on the cheek of this patient with discoid lupus erythematosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Discoid lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well-defined erythematous plaque with scale, pigmentary alteration, and scarring is present on this patient with discoid lupus erythematosus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17945=[""].join("\n");
var outline_f17_33_17945=null;
var title_f17_33_17946="Clinical manifestations, diagnosis, and staging of colorectal cancer";
var content_f17_33_17946=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations, diagnosis, and staging of colorectal cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Dennis J Ahnen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Finlay A Macrae, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Johanna Bendell, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/33/17946/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/33/17946/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colorectal cancer (CRC) is a common and lethal disease. It is estimated that approximately 142,820 new cases of large bowel cancer will be diagnosed in the United States in 2013 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/1\">",
"     1",
"    </a>",
"    ], including about 102,480 colon and 40,000 rectal cancers. Approximately 52,390 Americans are expected to die of large bowel cancer this year. Although CRC mortality has been progressively declining since 1990 at a rate of about 3 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/2\">",
"     2",
"    </a>",
"    ], it still remains the second most common cause of cancer death in the US.",
"   </p>",
"   <p>",
"    Surgical resection is the primary treatment modality for CRC, and outcome is most closely related to the extent of disease at presentation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link\">",
"     \"Pathology and prognostic determinants of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Screening with fecal occult blood testing, endoscopy, or radiology can lead to diagnosis at an earlier stage of disease and thereby reduce cause-specific mortality. Compliance with CRC screening guidelines is steadily improving but still relatively low; CRC continues to be diagnosed after the onset of symptoms in the majority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37034?source=see_link\">",
"     \"Screening for colorectal cancer: Strategies in patients at average risk\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical presentation, diagnosis, and staging of CRC will be reviewed here. The pathology, prognostic determinants, and treatment of colon and rectal cancer are discussed elsewhere.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link\">",
"       \"Pathology and prognostic determinants of colorectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30489?source=see_link\">",
"       \"Overview of the management of primary colon cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link\">",
"       \"Surgical oncologic principles for the resection of colon cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link\">",
"       \"Adjuvant therapy for resected stage III (node-positive) colon cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=see_link\">",
"       \"Adjuvant chemotherapy for resected stage II colon cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=see_link\">",
"       \"Adjuvant therapy for resected colon cancer in elderly patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38137?source=see_link\">",
"       \"Overview of surgical procedures for resectable primary rectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=see_link\">",
"       \"Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/51/4922?source=see_link\">",
"       \"Adjuvant therapy for resected rectal cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of CRC are typically due to growth of the tumor into the lumen or adjacent structures. As a result, symptomatic presentation is often a manifestation of relatively advanced CRC. The majority of patients presenting with symptomatic CRC have hematochezia or melena, abdominal pain, otherwise unexplained iron deficiency anemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a change in bowel habits [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link&amp;anchor=H37#H37\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\", section on 'Search for source of blood and iron loss'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The frequency of initial symptoms in patients presenting with a potentially resectable colon cancer is variable among reports [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/3,4\">",
"     3,4",
"    </a>",
"    ] but are in the ranges summarized below. Some patients have more than one presenting symptom:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abdominal pain &mdash; 44 percent",
"     </li>",
"     <li>",
"      Change in bowel habits &mdash; 43 percent",
"     </li>",
"     <li>",
"      Hematochezia or melena &mdash; 40 percent",
"     </li>",
"     <li>",
"      Weakness &mdash; 20 percent",
"     </li>",
"     <li>",
"      Anemia without other gastrointestinal symptoms &mdash; 11 percent",
"     </li>",
"     <li>",
"      Weight loss &mdash; 6 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A meta-analysis of 15 studies concluded that the sensitivity of individual symptoms for the diagnosis of CRC was poor (ranging from 5 to 64 percent), and specificity was limited, as would be expected for a low prevalence disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/5\">",
"     5",
"    </a>",
"    ]. However, the specificity for dark red rectal bleeding and abdominal mass was greater than 95 percent.",
"   </p>",
"   <p>",
"    Abdominal pain can be caused by a partial obstruction, peritoneal dissemination, or intestinal perforation leading to generalized peritonitis.",
"   </p>",
"   <p>",
"    A change in bowel habits is a more common presenting symptom for left- than right-sided CRCs because fecal contents are liquid in the proximal colon and the lumen caliber is larger, and they are therefore less likely to be associated with obstructive symptoms. Cancers can develop as plaque-like lesions or encircle the bowel producing the \"apple-core\" description seen on radiologic images (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82202 graphicRef75818 \" href=\"UTD.htm?35/18/36128\">",
"     image 1A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link\">",
"     \"Pathology and prognostic determinants of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hematochezia is more often caused by rectal than colon cancer. Iron deficiency anemia from unrecognized blood loss is more common with right sided CRCs and is frequently associated with a delayed diagnostic evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/6\">",
"     6",
"    </a>",
"    ]. Occult colonic bleeding is site but not stage dependent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]; cecal and ascending colon tumors have a fourfold higher mean daily blood loss (approximately 9",
"    <span class=\"nowrap\">",
"     mL/day)",
"    </span>",
"    than tumors at other colonic sites [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Weight loss is a common reason for referral of patients for colonoscopy but it is an uncommon sole presenting symptom in CRC. Its presence, however, has been reported to increase the likelihood of a given patient having colon cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/5,9\">",
"     5,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Less common, presenting symptoms of CRC include abdominal distention, nausea and vomiting, which may be an indication of obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Metastatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 20 percent of patients in the United States have distant metastatic disease at the time of presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/10\">",
"     10",
"    </a>",
"    ]. CRC can spread by lymphatic and hematogenous dissemination, as well as by contiguous and transperitoneal routes. The most common metastatic sites are the regional lymph nodes, liver, lungs, and peritoneum. Patients may present with signs or symptoms referable to any of these areas. The presence of right upper quadrant pain, abdominal distention, early satiety, supraclavicular adenopathy, or periumbilical nodules usually signals advanced often metastatic disease.",
"   </p>",
"   <p>",
"    Because the venous drainage of the intestinal tract is via the portal system, the first site of hematogenous dissemination is usually liver, followed by lungs, bone, and many other sites, including brain. However, tumors arising in the distal rectum may metastasize initially to the lungs because the inferior rectal vein drains into the inferior vena cava rather than into the portal venous system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Unusual presentations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a variety of atypical presentations of CRC. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local invasion or a contained perforation causing malignant fistula formation into adjacent organs, such as bladder (resulting in pneumaturia) or small bowel. This is most common with cecal or sigmoid carcinomas; in the latter case, the condition can mimic diverticulitis.",
"     </li>",
"     <li>",
"      Fever of unknown origin, intraabdominal, retroperitoneal, or abdominal wall abscesses. Streptococcus bovis bacteremia and Clostridium septicum sepsis are due to underlying colonic malignancies in about 10 to 25 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/33/22041?source=see_link&amp;anchor=H24506924#H24506924\">",
"       \"Clinical manifestations, diagnosis, and treatment of Streptococcus bovis infection\", section on 'Association with colonic neoplasia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CRC ultimately proves to be the origin of approximately 6 percent of adenocarcinomas of unknown primary sites [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28121?source=see_link\">",
"       \"Adenocarcinoma of unknown primary site\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Impact of symptoms on prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of symptoms and their particular type appear to be of some prognostic importance:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who are symptomatic at diagnosis typically have more advanced disease at presentation and thus have a worse prognosis [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/13,14\">",
"       13,14",
"      </a>",
"      ]. In one report, the five-year survival rate for symptomatic and asymptomatic patients was 49 versus 71 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/13\">",
"       13",
"      </a>",
"      ]. Screen detected (ie, asymptomatic) cancers are more likely to be diagnosed at a more favorable pathological stage [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/15\">",
"       15",
"      </a>",
"      ]. The total number of symptoms may be inversely related to survival for colon but not for rectal cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/16\">",
"       16",
"      </a>",
"      ]. Surprisingly, however, the duration of symptoms is not an accurate predictor of prognosis.",
"     </li>",
"     <li>",
"      Obstruction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      perforation, although uncommon, carry a poor prognosis, independent of stage [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/4,17-20\">",
"       4,17-20",
"      </a>",
"      ]. Among patients with node-negative colon cancer, obstruction or perforation is one of the poor prognostic factors that influences the decision to pursue adjuvant chemotherapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=see_link&amp;anchor=H589530408#H589530408\">",
"       \"Adjuvant chemotherapy for resected stage II colon cancer\", section on 'Clinicopathologic variables'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tumors presenting with hemorrhage have been thought to have a better prognosis because of their tendency to be diagnosed earlier; however, bleeding is not an independent predictor of outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/18,21\">",
"       18,21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other determinants of prognosis, including clinicopathologic and molecular features, are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link\">",
"     \"Pathology and prognostic determinants of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     LOCATION OF COLORECTAL MALIGNANCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The location of the primary tumor may also have prognostic significance. For each stage, cancers arising at or below the peritoneal reflection (rectosigmoid and rectum) have a worse five-year survival rate than those arising more proximally [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/18,22\">",
"     18,22",
"    </a>",
"    ]. Furthermore, within the rectum, distal cancers have a worse prognosis than more proximal lesions.",
"   </p>",
"   <p>",
"    Over the last 50 years, a gradual shift toward right-sided or proximal colon cancers has been observed both in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/23,24\">",
"     23,24",
"    </a>",
"    ] and internationally [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/24-27\">",
"     24-27",
"    </a>",
"    ]. As an example, data obtained from the Surveillance, Epidemiology, and End Results (SEER) database suggest that between 1978 and 1998, the proportion of all colon cancers that arose proximal to the splenic flexure increased from 34 to 40 percent in whites and from 37 to 44 percent in blacks [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/24\">",
"     24",
"    </a>",
"    ]. The greatest increase in incidence is in cecal primaries (",
"    <a class=\"graphic graphic_picture graphicRef51584 \" href=\"UTD.htm?26/24/27011\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=see_link\">",
"     \"Colorectal cancer: Epidemiology, risk factors, and protective factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Synchronous cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Synchronous CRCs, defined as two or more distinct primary tumors separated by normal bowel and not due to direct extension or metastasis, occur in 3 to 5 percent of patients with colon cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. The incidence is somewhat lower (about 2.5 percent) when patients with hereditary nonpolyposis colorectal cancer (see below) are excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/32\">",
"     32",
"    </a>",
"    ]. Synchronous primaries have the same prognosis as solitary malignancies when the highest stage of disease is compared [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Metachronous cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metachronous CRCs, defined as non-anastomotic new tumors developing at least six months after the initial diagnosis, develop in 1.5 to 3 percent of patients in the first five years postoperatively, rising to up to 9 percent after several decades in survivors of the primary cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=see_link\">",
"     \"Surveillance after colorectal cancer resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;CRC may be suspected from one or more of the symptoms and signs described above or may be asymptomatic and discovered by routine screening of average and high risk subjects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=see_link\">",
"     \"Colorectal cancer: Epidemiology, risk factors, and protective factors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=see_link\">",
"     \"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29783?source=see_link\">",
"     \"Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3224?source=see_link\">",
"     \"Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Colonoscopy, BE, and CT colonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of colon and rectal cancers are endoluminal adenocarcinomas that arise from the mucosa. Colonoscopy is the most accurate diagnostic test in symptomatic individuals, since it can localize and biopsy lesions throughout the large bowel, detect synchronous neoplasms, and remove polyps (",
"    <a class=\"graphic graphic_picture graphicRef74346 graphicRef54234 \" href=\"UTD.htm?23/45/24281\">",
"     picture 2A-B",
"    </a>",
"    ). Most colorectal cancers are protuberant masses but some are relatively flat or depressed. It is recognized that cancers can arise from nonpolypoid (flat) adenomas, which may be more difficult to visualize colonoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/33\">",
"     33",
"    </a>",
"    ]. The Paris classification was developed in an attempt to standardize the description of neoplastic lesions of the GI tract [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32746?source=see_link&amp;anchor=H15#H15\">",
"     \"Approach to the patient with colonic polyps\", section on 'Morphologic/endoscopic classification'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The air contrast",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema (BE), supplemented with flexible sigmoidoscopy, is sometimes used to evaluate symptomatic patients (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82202 graphicRef75818 \" href=\"UTD.htm?35/18/36128\">",
"     image 1A-B",
"    </a>",
"    ), but the diagnostic yield of this combination is less than that of colonoscopy for the evaluation of lower tract symptoms. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38042?source=see_link\">",
"     \"Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In approximately 5 percent of patients in whom the colonoscope is not able to reach the tumor for technical reasons (eg, partially obstructing cancer, tortuous colon, poor prep), double-contrast BE or CT colonography [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/35-37\">",
"     35-37",
"    </a>",
"    ] can provide a radiographic diagnosis, although they lack the capability for biopsy or removal of polyps. The emerging technology of capsule colonoscopy may have a role in the future. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36632?source=see_link\">",
"     \"Computed tomographic colonography\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38042?source=see_link&amp;anchor=H22#H22\">",
"     \"Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy\", section on 'Capsule endoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If colorectal cancer is found with any of these tests, the entire large bowel should be examined for the presence of synchronous lesions. If malignant obstruction precludes a full colonoscopy preoperatively, the entire residual colon should be examined soon after resection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of CRCs are adenocarcinomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link\">",
"     \"Pathology and prognostic determinants of colorectal cancer\"",
"    </a>",
"    .) Many conditions cause signs or symptoms that are similar to CRC, including other malignancies as well as benign lesions such as hemorrhoids, diverticulitis, infection, or inflammatory bowel disease. A direct evaluation of the total colonic mucosa is necessary to exclude carcinoma with certainty.",
"   </p>",
"   <p>",
"    The differential diagnosis of a colonic mass includes a number of benign and malignant disorders and generally requires histologic evaluation (",
"    <a class=\"graphic graphic_table graphicRef66850 \" href=\"UTD.htm?17/55/18299\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    Rare malignancies other than adenocarcinomas which are primary to the large bowel include Kaposi's sarcoma (KS), lymphomas, and carcinoid tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathology and prognostic determinants of colorectal cancer\", section on 'Histologic type'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Disseminated KS can involve the colon, particularly in patients with AIDS, manifested as characteristic violaceous macules or nodules [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/38\">",
"       38",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12103?source=see_link&amp;anchor=H432027028#H432027028\">",
"       \"AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis\", section on 'Gastrointestinal tract'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Primary non-Hodgkin lymphoma of the large bowel most commonly arises in the cecum, right colon or rectum and usually presents at an advanced stage in adults. Colonic lymphoma typically appears as a large solitary mass, although multiple polypoid lesions or diffuse involvement can occur [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/39\">",
"       39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=see_link\">",
"       \"Clinical presentation and diagnosis of primary gastrointestinal lymphomas\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Colonic carcinoid tumors are found most commonly in the appendix, rectum, and cecum and they tend to develop at a younger age than adenocarcinomas of the colon. Appendiceal and rectal carcinoids, most of which are less than 2 cm, appear as submucosal nodules and tend to be indolent. In contrast, primary colonic carcinoid tumors can present as large apple core lesions, which can be clinically aggressive and may metastasize. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=see_link\">",
"       \"Clinical characteristics of carcinoid tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metastases from other primary cancers, most often ovarian cancer, can mimic a primary large bowel malignancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31849?source=see_link&amp;anchor=H31#H31\">",
"       \"Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis is established, the local and distant extent of disease spread is determined to provide a framework for discussing therapy and prognosis. A review of the biopsy specimen is important prior to making a decision about the need for clinical staging studies and surgical resection, especially for a cancerous polyp. Polyps with an area of invasive malignancy that have been completely removed and lack associated adverse histologic features (positive margin, poor differentiation, lymphovascular invasion) have a low risk of lymphatic and distant metastases; in such patients, polypectomy alone may be adequate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32746?source=see_link\">",
"     \"Approach to the patient with colonic polyps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     TNM staging system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The TNM staging system of the",
"    <span class=\"nowrap\">",
"     AJCC/UICC",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 2",
"    </a>",
"    ) is the preferred staging system for CRC [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/40\">",
"     40",
"    </a>",
"    ]. Use of the older Astler-Coller modification of the Duke's classification is discouraged.",
"   </p>",
"   <p>",
"    The most recent 2010 TNM staging classification includes a number of changes compared to the older 2002 classification [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/40\">",
"     40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Subdivision of T4 lesions into T4a (tumor perforates the surface of the visceral peritoneum), and T4b (direct invasion or histologic adherence to other organs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      structures).",
"     </li>",
"     <li>",
"      Further substaging of stage II into IIA (T3N0), IIB (T4aN0) and IIC (T4bN0) disease.",
"     </li>",
"     <li>",
"      N1 and N2 categories are subdivided according to the number of involved nodes.",
"     </li>",
"     <li>",
"      Satellite deposits that are discontinuous from the leading edge of the cancer and lack evidence of a residual lymph node are classified as N1c disease.",
"     </li>",
"     <li>",
"      Several stage groupings of stage III disease have been revised based upon refinement in prognostic stratification.",
"     </li>",
"     <li>",
"      M1 is subdivided into M1a for single metastatic site and M1b for multiple metastatic sites.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These changes were supported by analysis of data on both colon and rectum cancer from the population-based SEER registry [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. However, the revised edition of the TNM staging classification is not used in all countries. As examples, in some areas of the Netherlands, the 5",
"    <sup>",
"     th",
"    </sup>",
"    edition of the TNM staging classification is still used purposely for rectal cancer as later modifications were not considered to represent an improvement, whereas in Japan, none of the revised criteria on satellite deposits that lack evidence of a residual lymph node were adopted in the 7",
"    <sup>",
"     th",
"    </sup>",
"    edition of the National Cancer Staging Manual edited by the Japanese Society for Cancer of the Colon and Rectum because of the lack of sufficient justification for this change [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/43\">",
"     43",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Radiographic, endoscopic, and intraoperative findings can be used to assign a clinical stage, while assessment of the pathologic stage (termed pT, pN, pM) requires histologic examination of the resection specimen. Preoperative radiation and chemotherapy can significantly alter clinical staging [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/44\">",
"     44",
"    </a>",
"    ]; as a result, posttherapy pathologic staging is designated with a yp prefix (ie, ypT, ypN). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link\">",
"     \"Pathology and prognostic determinants of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of note, lateral pelvic lymph nodes (eg, internal iliac and lateral sacral nodes) are considered regional nodes in the TNM staging system [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/40\">",
"     40",
"    </a>",
"    ]. However, lateral pelvic nodal metastases beyond the internal iliac area are associated with a poorer survival [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Clinical staging evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative clinical staging is best accomplished by physical examination (with particular attention to ascites, hepatomegaly and lymphadenopathy), CT scan of the abdomen and pelvis, and chest imaging. Although frequently obtained preoperatively, liver enzymes may be normal in the setting of small hepatic metastases and are not a reliable marker for exclusion of liver involvement (",
"    <a class=\"graphic graphic_picture graphicRef81255 \" href=\"UTD.htm?29/44/30402\">",
"     picture 3",
"    </a>",
"    ). The single most common liver test abnormality associated with liver metastases is an elevation in the serum alkaline phosphatase level [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with newly diagnosed CRC, preoperative abdominal and pelvic CT scans can demonstrate regional tumor extension, regional lymphatic and distant metastases, and tumor-related complications (eg, obstruction, perforation, fistula formation) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. The sensitivity of CT for detecting distant metastasis is higher (75 to 87 percent) than for detecting nodal involvement (45 to 73 percent) or the depth of transmural invasion (approximately 50 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/48,50-54\">",
"     48,50-54",
"    </a>",
"    ]. The sensitivity of CT for detection of malignant lymph nodes is higher for rectal than for colon cancers; any perirectal adenopathy is presumed to be malignant since benign adenopathy is typically not seen in this area [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT scan is not a reliable diagnostic test for low volume tumor on peritoneal surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/56\">",
"     56",
"    </a>",
"    ]. The sensitivity of CT for detecting peritoneal implants depends on the location and size of the implants. In one study, the sensitivity of CT for nodules &lt;0.5 cm was 11 percent, and it was only 37 percent for implants 0.5 to 5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although commonly obtained, the necessity of preoperative",
"    <span class=\"nowrap\">",
"     abdominal/pelvic",
"    </span>",
"    CT for all patients with CRC is debated. In a retrospective review of 180 resected patients, only three of 67 patients had incidental findings on CT that altered the surgical approach [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/53\">",
"     53",
"    </a>",
"    ]. Assessment of hepatic metastases by intraoperative ultrasound and manual palpation of the liver may provide a better yield than preoperative CT, particularly for patients who are found to have transmural involvement",
"    <span class=\"nowrap\">",
"     (T3/4)",
"    </span>",
"    at the time of exploration [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/58-60\">",
"     58-60",
"    </a>",
"    ]. However, the increasing use of laparoscopic colonic resections precludes manual palpation, and even with open procedures surgeons may not have adequate access to the liver depending upon the location of the incision and the extent of adhesions from prior surgery.",
"   </p>",
"   <p>",
"    The finding of liver metastases on preoperative studies may not necessarily alter the surgical approach to the primary tumor, particularly in patients who are symptomatic from their primary tumor (eg, bleeding, impending obstruction). In patients with four or fewer hepatic lesions, resection may be curative, with five-year relapse-free survival rates of 24 to 38 percent. Although most surgeons advocate resection of the primary tumor and synchronous hepatic metastases at two different operations, some approach both sites at the same time. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical benefit of a staging chest CT is also controversial. There are few studies describing the outcome and clinical relevance of a preoperative chest CT [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/61-65\">",
"     61-65",
"    </a>",
"    ]. The major issue is the frequent finding of indeterminate lesions (20 to 30 percent), which add to the clinical complexity but are seldom malignant (7 to 20 percent). In theory, imaging of the chest might be of more value for rectal cancer since venous drainage of the lower rectum is through the hemorrhoidal veins to the vena cava, bypassing the liver.",
"   </p>",
"   <p>",
"    In the US, the standard practice at most institutions is that all patients with stage II, III, or IV colorectal cancer undergo chest, abdomen and pelvic CT, either prior to or following resection, an approach endorsed by the NCCN [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/66\">",
"     66",
"    </a>",
"    ]. It is preferable to&nbsp;obtain these scans prior to, rather than after operation, as the scan results will occasionally change&nbsp;surgical planning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Liver MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contrast-enhanced magnetic resonance imaging (MRI) of the liver identifies more hepatic lesions than are visualized by CT, and a meta-analysis concluded that MRI is the preferred first-line imaging study for evaluating colorectal cancer liver metastases in patients who have not previously undergone therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H4#H4\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Patient selection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     PET scans",
"    </span>",
"    &nbsp;&mdash;&nbsp;PET scans do not appear to add significant information to CT scans for routine preoperative staging of CRC [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. The established role of PET scanning in patients with colorectal cancer as an adjunct to other imaging modalities is in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Localizing site(s) of disease recurrence in patients who have a rising serum CEA level and nondiagnostic conventional imaging evaluation following primary treatment. In this setting, PET scanning can potentially localize occult disease, permitting the selection of patients who may benefit from exploratory laparotomy [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/70-73\">",
"       70-73",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=see_link\">",
"       \"Surveillance after colorectal cancer resection\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In an illustrative series, 105 such patients underwent PET scanning and subsequent abdominopelvic CT scans [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/70\">",
"       70",
"      </a>",
"      ]. Compared to CT and other conventional diagnostic studies, PET scanning had a higher sensitivity (87 versus 66 percent) and specificity (68 versus 59 percent). In a second report, PET scan findings led to a potentially curative resection in 14 of 50 patients (28 percent) with elevated serum CEA levels and a completely normal or equivocal conventional diagnostic work-up [",
"      <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Evaluation of patients who are thought to be candidates for resection of isolated colorectal cancer liver metastases. The routine use of PET prior to attempted resection reduces the number of nontherapeutic laparotomies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H6#H6\">",
"       \"Management of potentially resectable colorectal cancer liver metastases\", section on 'PET scans'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recent chemotherapy may alter the sensitivity of PET for the detection of colorectal liver metastases, an effect thought related to decreased cellular metabolic activity of the tumor. This subject is addressed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H6#H6\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'PET scans'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H625807\">",
"    <span class=\"h3\">",
"     Locoregional staging for rectal cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;An accurate determination of tumor location within the rectum and disease extent is necessary prior to treatment in order to select the surgical approach and to identify those patients who are candidates for initial radiotherapy or chemoradiotherapy rather than surgery. Digital rectal examination (DRE), rigid sigmoidoscopy, transrectal ultrasound, transrectal endoscopic ultrasound, and MRI can all assist in determining the need for radical resection versus local excision, and whether the patient is a candidate for preoperative therapy. This subject is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6041?source=see_link\">",
"     \"Pretreatment local staging evaluation for rectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     TUMOR MARKERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of serum markers have been associated with CRC, particularly carcinoembryonic antigen (CEA), and carbohydrate antigen (CA) 19-9. However, these markers have a low diagnostic ability to detect primary CRC due to significant overlap with benign disease and low sensitivity for early stage disease [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/74-77\">",
"     74-77",
"    </a>",
"    ]. Non-cancer-related causes of an elevated CEA include gastritis, peptic ulcer disease, diverticulitis, liver disease, chronic obstructive pulmonary disease, diabetes, and any acute or chronic inflammatory state.",
"   </p>",
"   <p>",
"    An expert panel on tumor markers in breast and colorectal cancer convened by the American Society of Clinical Oncology (ASCO) recommended that serum CEA nor CA 19-9 levels",
"    <strong>",
"     not",
"    </strong>",
"    be used as a screening test for colorectal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/75\">",
"     75",
"    </a>",
"    ]. A similar recommendation has been made by the European Group on Tumor Markers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, serum levels of CEA do have prognostic utility in patients with newly diagnosed CRC. Patients with preoperative serum CEA &gt;5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    have a worse prognosis, stage for stage, than those with lower levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link&amp;anchor=H12#H12\">",
"     \"Pathology and prognostic determinants of colorectal cancer\", section on 'Category I factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Furthermore, elevated preoperative CEA levels that do not normalize following surgical resection imply the presence of persistent disease and the need for further evaluation. ASCO guidelines recommend that serum CEA levels be obtained preoperatively in most patients with demonstrated colorectal cancer to aid in surgical treatment planning, posttreatment follow up, and in the assessment of prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/75\">",
"     75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=see_link\">",
"     \"Surveillance after colorectal cancer resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the enormous number of correlative studies exploring the prognostic significance of various histologic, molecular, and clinical features, the pathologic stage at diagnosis remains the best indicator of long-term prognosis for both colon and rectal cancer. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Colon cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important indicator of outcome following resection of colon cancer is the pathologic stage at presentation. The survival of patients with stage III disease is especially variable and depends upon the T stage and the extent of nodal disease.",
"   </p>",
"   <p>",
"    Five-year survival rates according to tumor stage at diagnosis (using the older 2002 AJCC staging criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/79\">",
"     79",
"    </a>",
"    ]) for 119,363 patients with colon cancer reported to the SEER (Surveillance, Epidemiology and End Results) database between 1991 and 2000 were as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/80\">",
"     80",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stage I (T1-2 N0) &mdash; 93 percent",
"     </li>",
"     <li>",
"      Stage IIA (T3N0) &mdash; 85 percent",
"     </li>",
"     <li>",
"      Stage IIB (T4N0) &mdash; 72 percent",
"     </li>",
"     <li>",
"      Stage IIIA (T1-2 N1) &mdash; 83 percent",
"     </li>",
"     <li>",
"      Stage IIIB (T3-4 N1) &mdash; 64 percent",
"     </li>",
"     <li>",
"      Stage IIIC (N2 disease) &mdash; 44 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Five-year survival according to tumor stage at diagnosis for a smaller group of patients with colon cancer reported to the database between 1998 and 2000 and stratified according to the most recent 2010 AJCC staging criteria are illustrated in the figure (",
"    <a class=\"graphic graphic_figure graphicRef81414 \" href=\"UTD.htm?40/54/41824\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/40\">",
"     40",
"    </a>",
"    ]. These comparative data are presented to illustrate the prognostic stratification of the newer 2010 AJCC staging criteria. The differences in staging between the two editions of the TNM staging criteria are outlined above (see",
"    <a class=\"local\" href=\"#H13\">",
"     'TNM staging system'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Rectal cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with colon cancer, the survival of patients with stage III disease is variable and depends both upon the T stage and the extent of nodal disease. Five-year survival stratified by tumor stage at diagnosis for rectal cancer, derived from the SEER database and stratified according to the 2010 AJCC staging criteria, is illustrated in the following figure (",
"    <a class=\"graphic graphic_figure graphicRef60598 \" href=\"UTD.htm?0/63/1009\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These outcome estimates were derived from studies in which surgical resection was not preceded by neoadjuvant therapy. Outcomes may differ in patients who undergo pathologic staging after preoperative treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link&amp;anchor=H20#H20\">",
"     \"Pathology and prognostic determinants of colorectal cancer\", section on 'Category IIA factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Impact of additional prognostic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other clinicopathologic and molecular factors provide prognostic information beyond that achieved by disease stage (",
"    <a class=\"graphic graphic_table graphicRef72913 \" href=\"UTD.htm?23/26/23982\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although not used for staging, prognostic factors recommended for collection in the most recent TNM staging manual include pretreatment carcinoembryonic antigen (CEA) levels, the status of the circumferential resection margin, the presence or absence of perineural invasion, microsatellite instability (MSI), and tumor regression grade (for tumors undergoing neoadjuvant therapy). These factors are discussed in detail elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link&amp;anchor=H11#H11\">",
"     \"Pathology and prognostic determinants of colorectal cancer\", section on 'Prognostic determinants'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H20\">",
"     'Tumor markers'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The prognostic value of a wide variety of other potentially clinically useful molecular markers has been studied in CRC. However, an exhaustive review of data on many of these molecular markers by the American Society of Clinical Oncology concluded that there was insufficient evidence to recommend the routine use of p53, thymidine synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, microsatellite instability (MSI), 18q loss of heterozygosity, or deleted in colon cancer (DCC) protein in the management of patients with colorectal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/75\">",
"     75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=see_link&amp;anchor=H29#H29\">",
"     \"Pathology and prognostic determinants of colorectal cancer\", section on 'Category III factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MSI testing of CRCs is routinely used to help establish the diagnosis of Lynch syndrome. Failure of the mismatch repair (MMR) mechanism of DNA repair results in MSI. Although over 90 percent of Lynch syndrome (sometimes called hereditary non-polyposis colorectal cancer) related colorectal cancers will demonstrate MSI, 15 percent of sporadic colorectal cancers also demonstrate MSI due to hypermethylation-induced silencing of the DNA mismatch repair gene",
"    <em>",
"     MLH1",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. Some institutions perform MSI testing or immunohistochemistry (IHC) testing for DNA mismatch repair proteins in colorectal cancers in young patients (diagnosed prior to age 50 years) or in those who meet the Bethesda criteria (",
"    <a class=\"graphic graphic_table graphicRef72965 \" href=\"UTD.htm?41/48/42763\">",
"     table 3",
"    </a>",
"    ). At other institutions, universal testing of all colorectal cancers for MSI or IHC is practiced because of its greater sensitivity for detecting Lynch syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/83\">",
"     83",
"    </a>",
"    ]. One algorithmic approach to making a diagnosis of Lynch syndrome in patients with colorectal cancer is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef75385 \" href=\"UTD.htm?18/49/19218\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The place of genetic counseling before tumor testing for Lynch syndrome is controversial. The practice in many countries is to screen tumors by MSI or IHC and offer genetic counseling with germline mutational analysis only when tumor testing indicates possible Lynch syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?17/33/17946/abstract/84\">",
"     84",
"    </a>",
"    ]. This subject is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\", section on 'Identification of individuals with Lynch syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to identifying patients who might have Lynch syndrome, MSI testing is increasingly used as an aid to adjuvant chemotherapy decision-making in patients with stage II disease. Patients with MSI-high (MSI-H) tumors have a better prognosis than do those with microsatellite-stable tumors, and adjuvant fluoropyrimidine-based chemotherapy does not appear to benefit those with MSI-H tumors and may in fact be potentially detrimental. These data are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=see_link&amp;anchor=H589530422#H589530422\">",
"     \"Adjuvant chemotherapy for resected stage II colon cancer\", section on 'MSI and mismatch repair enzyme deficiency'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=see_link\">",
"       \"Patient information: Colon and rectal cancer (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=see_link\">",
"       \"Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H625914\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Outcomes are best when colorectal cancers are diagnosed while still asymptomatic. Both the incidence and mortality from colorectal cancer can be significantly decreased by population screening for colorectal cancer. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37034?source=see_link\">",
"       \"Screening for colorectal cancer: Strategies in patients at average risk\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/41/9881?source=see_link\">",
"       \"Screening for colorectal cancer: Strategies in patients with possible increased risk due to family history\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      The majority of patients presenting with symptomatic CRC have hematochezia or melena, abdominal pain, otherwise unexplained iron deficiency anemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a change in bowel habits. A change in bowel habits is a more common presenting symptom for left-sided cancers. Hematochezia is more likely with rectal than colon cancers but occult colonic bleeding is more common with cecal and ascending colon cancers. Most early colorectal cancers are asymptomatic and symptoms are not a sensitive indicator of colorectal cancer. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      One in five patients with colorectal cancer presents with metastatic disease. The most common metastatic sites are the regional lymph nodes, liver, lungs, and peritoneum. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Metastatic disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The vast majority of colon and rectal cancers are endoluminal adenocarcinomas that arise from the mucosa. Colonoscopy is the single best diagnostic test in symptomatic individuals, since it can localize and biopsy lesions throughout the large bowel, detect synchronous neoplasms, and remove polyps. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Colonoscopy, BE, and CT colonography'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      In patients in whom the colonoscope is not able to reach the tumor for technical reasons (eg, partially obstructing cancer, tortuous colon, poor prep), double-contrast BE or CT colonography can provide a radiographic diagnosis.",
"     </li>",
"     <li>",
"      Once the diagnosis is established, the local and distant extent of disease spread is determined to provide a framework for discussing therapy and prognosis.",
"      <br/>",
"      <br/>",
"      Preoperative clinical staging is best accomplished by physical examination, CT scan of the abdomen and pelvis, and chest imaging. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Clinical staging evaluation'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      PET scans do not appear to add significant information to CT scans for routine preoperative staging of a newly diagnosed CRC except for the evaluation of patients who are thought to be candidates for resection of isolated colorectal cancer liver metastases. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'PET scans'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Additional procedures (digital rectal examination [DRE], rigid sigmoidoscopy, transrectal endoscopic ultrasound,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      MRI) are indicated for locoregional staging of patients with rectal cancer to select the surgical approach and to identify those patients who are candidates for initial radiotherapy or chemoradiotherapy rather than surgery. (See",
"      <a class=\"local\" href=\"#H625807\">",
"       'Locoregional staging for rectal cancer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serum CEA levels should be obtained preoperatively in patients with demonstrated colorectal cancer to aid surgical treatment planning, assessment of prognosis and follow-up. Elevated preoperative CEA levels that do not normalize following surgical resection imply the presence of persistent disease and the need for further evaluation. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Tumor markers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important indicator of outcome following resection of colon cancer is the pathologic stage at presentation. Stage for stage, cancers arising at or below the peritoneal reflection (rectosigmoid and rectum) have a worse five-year survival rate than those arising more proximally. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/1\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/2\">",
"      Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013; 105:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/3\">",
"      Speights VO, Johnson MW, Stoltenberg PH, et al. Colorectal cancer: current trends in initial clinical manifestations. South Med J 1991; 84:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/4\">",
"      Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer 1986; 57:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/5\">",
"      Ford AC, Veldhuyzen van Zanten SJ, Rodgers CC, et al. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut 2008; 57:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/6\">",
"      Goodman D, Irvin TT. Delay in the diagnosis and prognosis of carcinoma of the right colon. Br J Surg 1993; 80:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/7\">",
"      Macrae FA, St John DJ. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/8\">",
"      Joosten E, Meeuwissen J, Vandewinckele H, Hiele M. Iron status and colorectal cancer in symptomatic elderly patients. Am J Med 2008; 121:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/9\">",
"      Adelstein BA, Macaskill P, Chan SF, et al. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review. BMC Gastroenterol 2011; 11:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/10\">",
"      Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/11\">",
"      Panwalker AP. Unusual infections associated with colorectal cancer. Rev Infect Dis 1988; 10:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/12\">",
"      Abbruzzese JL, Abbruzzese MC, Lenzi R, et al. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995; 13:2094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/13\">",
"      Beahrs OH, Sanfelippo PM. Factors in prognosis of colon and rectal cancer. Cancer 1971; 28:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/14\">",
"      Copeland EM, Miller LD, Jones RS. Prognostic factors in carcinoma of the colon and rectum. Am J Surg 1968; 116:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/15\">",
"      Ananda SS, McLaughlin SJ, Chen F, et al. Initial impact of Australia's National Bowel Cancer Screening Program. Med J Aust 2009; 191:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/16\">",
"      Polissar L, Sim D, Francis A. Survival of colorectal cancer patients in relation to duration of symptoms and other prognostic factors. Dis Colon Rectum 1981; 24:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/17\">",
"      Griffin MR, Bergstralh EJ, Coffey RJ, et al. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987; 60:2318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/18\">",
"      Wolmark N, Wieand HS, Rockette HE, et al. The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. Ann Surg 1983; 198:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/19\">",
"      Carraro PG, Segala M, Cesana BM, Tiberio G. Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery. Dis Colon Rectum 2001; 44:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/20\">",
"      Crucitti F, Sofo L, Doglietto GB, et al. Prognostic factors in colorectal cancer: current status and new trends. J Surg Oncol Suppl 1991; 2:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/21\">",
"      Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985; 72:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/22\">",
"      Halvorsen TB, Johannesen E. DNA ploidy, tumour site, and prognosis in colorectal cancer. A flow cytometric study of paraffin-embedded tissue. Scand J Gastroenterol 1990; 25:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/23\">",
"      Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 1999; 85:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/24\">",
"      Jessup JM, McGinnis LS, Steele GD Jr, et al. The National Cancer Data Base. Report on colon cancer. Cancer 1996; 78:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/25\">",
"      Th&ouml;rn M, Bergstr&ouml;m R, Kressner U, et al. Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time period, and birth cohort. Cancer Causes Control 1998; 9:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/26\">",
"      Stewart RJ, Stewart AW, Turnbull PR, Isbister WH. Sex differences in subsite incidence of large-bowel cancer. Dis Colon Rectum 1983; 26:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/27\">",
"      Rabeneck L, Davila JA, El-Serag HB. Is there a true \"shift\" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol 2003; 98:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/28\">",
"      Mamazza J, Gordon PH. The changing distribution of large intestinal cancer. Dis Colon Rectum 1982; 25:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/29\">",
"      Vukasin AP, Ballantyne GH, Flannery JT, et al. Increasing incidence of cecal and sigmoid carcinoma. Data from the Connecticut Tumor Registry. Cancer 1990; 66:2442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/30\">",
"      Langevin JM, Nivatvongs S. The true incidence of synchronous cancer of the large bowel. A prospective study. Am J Surg 1984; 147:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/31\">",
"      Passman MA, Pommier RF, Vetto JT. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum 1996; 39:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/32\">",
"      Fante R, Roncucci L, Tamassia MG, et al. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma. Cancer 1996; 77:2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/33\">",
"      Soetikno RM, Kaltenbach T, Rouse RV, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008; 299:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/34\">",
"      The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/35\">",
"      Morrin MM, Farrell RJ, Raptopoulos V, et al. Role of virtual computed tomographic colonography in patients with colorectal cancers and obstructing colorectal lesions. Dis Colon Rectum 2000; 43:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/36\">",
"      Macari M, Berman P, Dicker M, et al. Usefulness of CT colonography in patients with incomplete colonoscopy. AJR Am J Roentgenol 1999; 173:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/37\">",
"      Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis. Radiology 2011; 259:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/38\">",
"      Friedman SL, Wright TL, Altman DF. Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology 1985; 89:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/39\">",
"      Busch E, Rodriguez-Bigas M, Mamounas E, et al. Primary colorectal non-Hodgkin's lymphoma. Ann Surg Oncol 1994; 1:222.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th edition, Edge, SB, Byrd, DR, Compton, CC, et al (Eds) (Eds), Springer, New York 2010. p.143.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/41\">",
"      Gunderson LL, Jessup JM, Sargent DJ, et al. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol 2010; 28:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/42\">",
"      Gunderson LL, Jessup JM, Sargent DJ, et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010; 28:264.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.kanehara-shuppan.co.jp/catalog/detail.html?isbn=9784307202442 (Accessed on May 03, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/44\">",
"      Song JS, Chang HJ, Kim DY, et al. Is the N1c category of the new American Joint Committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy? Cancer 2011; 117:3917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/45\">",
"      Akiyoshi T, Watanabe T, Miyata S, et al. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg 2012; 255:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/46\">",
"      Quadros CA, Falc&atilde;o MF, Carvalho ME, et al. Metastases to retroperitoneal or lateral pelvic lymph nodes indicated unfavorable survival and high pelvic recurrence rates in a cohort of 102 patients with low rectal adenocarcinoma. J Surg Oncol 2012; 106:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/47\">",
"      Niederhuber JE. Colon and rectum cancer. Patterns of spread and implications for workup. Cancer 1993; 71:4187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/48\">",
"      Taylor AJ, Youker JE. Imaging in colorectal carcinoma. Semin Oncol 1991; 18:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/49\">",
"      Horton KM, Abrams RA, Fishman EK. Spiral CT of colon cancer: imaging features and role in management. Radiographics 2000; 20:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/50\">",
"      Hundt W, Braunschweig R, Reiser M. Evaluation of spiral CT in staging of colon and rectum carcinoma. Eur Radiol 1999; 9:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/51\">",
"      Isbister WH, al-Sanea O. The utility of pre-operative abdominal computerized tomography scanning in colorectal surgery. J R Coll Surg Edinb 1996; 41:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/52\">",
"      Balthazar EJ, Megibow AJ, Hulnick D, Naidich DP. Carcinoma of the colon: detection and preoperative staging by CT. AJR Am J Roentgenol 1988; 150:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/53\">",
"      McAndrew MR, Saba AK. Efficacy of routine preoperative computed tomography scans in colon cancer. Am Surg 1999; 65:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/54\">",
"      Valls C, Lopez E, Gum&agrave; A, et al. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. AJR Am J Roentgenol 1998; 170:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/55\">",
"      Thoeni RF. Colorectal cancer. Radiologic staging. Radiol Clin North Am 1997; 35:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/56\">",
"      Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993; 72:1631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/57\">",
"      Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 2009; 16:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/58\">",
"      Milsom JW, Jerby BL, Kessler H, et al. Prospective, blinded comparison of laparoscopic ultrasonography vs. contrast-enhanced computerized tomography for liver assessment in patients undergoing colorectal carcinoma surgery. Dis Colon Rectum 2000; 43:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/59\">",
"      Stone MD, Kane R, Bothe A Jr, et al. Intraoperative ultrasound imaging of the liver at the time of colorectal cancer resection. Arch Surg 1994; 129:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/60\">",
"      Machi J, Isomoto H, Yamashita Y, et al. Intraoperative ultrasonography in screening for liver metastases from colorectal cancer: comparative accuracy with traditional procedures. Surgery 1987; 101:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/61\">",
"      Kronawitter U, Kemeny NE, Heelan R, et al. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999; 86:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/62\">",
"      McIntosh J, Sylvester PA, Virjee J, et al. Pulmonary staging in colorectal cancer--is computerised tomography the answer? Ann R Coll Surg Engl 2005; 87:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/63\">",
"      Brent A, Talbot R, Coyne J, Nash G. Should indeterminate lung lesions reported on staging CT scans influence the management of patients with colorectal cancer? Colorectal Dis 2007; 9:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/64\">",
"      Grossmann I, Avenarius JK, Mastboom WJ, Klaase JM. Preoperative staging with chest CT in patients with colorectal carcinoma: not as a routine procedure. Ann Surg Oncol 2010; 17:2045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/65\">",
"      Kirke R, Rajesh A, Verma R, Bankart MJ. Rectal cancer: incidence of pulmonary metastases on thoracic CT and correlation with T staging. J Comput Assist Tomogr 2007; 31:569.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidlines available online at www.nccn.org (Accessed on March 14, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/67\">",
"      Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010; 257:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/68\">",
"      Furukawa H, Ikuma H, Seki A, et al. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer. Gut 2006; 55:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/69\">",
"      Nahas CS, Akhurst T, Yeung H, et al. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation. Ann Surg Oncol 2008; 15:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/70\">",
"      Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 43:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/71\">",
"      Flamen P, Hoekstra OS, Homans F, et al. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer 2001; 37:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/72\">",
"      Libutti SK, Alexander HR Jr, Choyke P, et al. A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. Ann Surg Oncol 2001; 8:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/73\">",
"      Flanagan FL, Dehdashti F, Ogunbiyi OA, et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/74\">",
"      Macdonald JS. Carcinoembryonic antigen screening: pros and cons. Semin Oncol 1999; 26:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/75\">",
"      Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24:5313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/76\">",
"      Palmqvist R, Engar&aring;s B, Lindmark G, et al. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study. Dis Colon Rectum 2003; 46:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/77\">",
"      van der Schouw YT, Verbeek AL, Wobbes T, et al. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma. Br J Cancer 1992; 66:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/78\">",
"      Duffy MJ, van Dalen A, Haglund C, et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003; 39:718.",
"     </a>",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, Greene FL, Page DL, Fleming ID, et al (Eds), Springer, New York 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/80\">",
"      O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/81\">",
"      Ionov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/82\">",
"      Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/83\">",
"      Moreira L, Balaguer F, Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012; 308:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/33/17946/abstract/84\">",
"      Southey MC, Jenkins MA, Mead L, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005; 23:6524.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2496 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-EA571C30FB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17946=[""].join("\n");
var outline_f17_33_17946=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H625914\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Unusual presentations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Impact of symptoms on prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      LOCATION OF COLORECTAL MALIGNANCIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Synchronous cancers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Metachronous cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Colonoscopy, BE, and CT colonography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TNM staging system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Clinical staging evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - CT scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Liver MRI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - PET scans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H625807\">",
"      - Locoregional staging for rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      TUMOR MARKERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Colon cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Impact of additional prognostic factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H625914\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2496\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2496|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?18/49/19218\" title=\"algorithm 1\">",
"      Testing algorithm for Lynch syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2496|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/14/10478\" title=\"diagnostic image 1A\">",
"      Rectal cancer BE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/14/8431\" title=\"diagnostic image 1B\">",
"      Annular CA descend colon BE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2496|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/54/41824\" title=\"figure 1\">",
"      SEER surv adeno colon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/63/1009\" title=\"figure 2\">",
"      SEER surv adeno rectum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2496|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/24/27011\" title=\"picture 1\">",
"      Familial colon cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/21/40277\" title=\"picture 2A\">",
"      Adenocarcinoma colon Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/46/2788\" title=\"picture 2B\">",
"      Necrotic adenoca colon Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/44/30402\" title=\"picture 3\">",
"      Liver mets colon cancer Gross",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2496|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/55/18299\" title=\"table 1\">",
"      Causes of a colonic mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/26/23982\" title=\"table 2\">",
"      2010 TNM staging colorectal CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/48/42763\" title=\"table 3\">",
"      Revised Bethesda criteria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12103?source=related_link\">",
"      AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28121?source=related_link\">",
"      Adenocarcinoma of unknown primary site",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/55/30586?source=related_link\">",
"      Adjuvant chemotherapy for resected stage II colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/51/11066?source=related_link\">",
"      Adjuvant therapy for resected colon cancer in elderly patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/51/4922?source=related_link\">",
"      Adjuvant therapy for resected rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=related_link\">",
"      Adjuvant therapy for resected stage III (node-positive) colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/62/32746?source=related_link\">",
"      Approach to the patient with colonic polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=related_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=related_link\">",
"      Clinical characteristics of carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/33/22041?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of Streptococcus bovis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8714?source=related_link\">",
"      Clinical presentation and diagnosis of primary gastrointestinal lymphomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/25/42394?source=related_link\">",
"      Colorectal cancer: Epidemiology, risk factors, and protective factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36632?source=related_link\">",
"      Computed tomographic colonography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31849?source=related_link\">",
"      Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=related_link\">",
"      Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/5/29783?source=related_link\">",
"      Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=related_link\">",
"      Management of potentially resectable colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42346?source=related_link\">",
"      Neoadjuvant chemoradiotherapy and radiotherapy for rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38137?source=related_link\">",
"      Overview of surgical procedures for resectable primary rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30489?source=related_link\">",
"      Overview of the management of primary colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/34/41514?source=related_link\">",
"      Pathology and prognostic determinants of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/0/6148?source=related_link\">",
"      Patient information: Colon and rectal cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/27/19890?source=related_link\">",
"      Patient information: Colon and rectal cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/22/40293?source=related_link\">",
"      Patient information: Colorectal cancer treatment; metastatic cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3224?source=related_link\">",
"      Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/57/6041?source=related_link\">",
"      Pretreatment local staging evaluation for rectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/10/37034?source=related_link\">",
"      Screening for colorectal cancer: Strategies in patients at average risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/41/9881?source=related_link\">",
"      Screening for colorectal cancer: Strategies in patients with possible increased risk due to family history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=related_link\">",
"      Surgical oncologic principles for the resection of colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/61/28634?source=related_link\">",
"      Surveillance after colorectal cancer resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38042?source=related_link\">",
"      Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_33_17947="Heart rates in normal children";
var content_f17_33_17947=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77057&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77057&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Heart rates in normal children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\">",
"        Awake rate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sleeping rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Newborn to 3 months",
"       </td>",
"       <td>",
"        85-205",
"       </td>",
"       <td>",
"        140",
"       </td>",
"       <td>",
"        80-160",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 months to 2 years",
"       </td>",
"       <td>",
"        100-190",
"       </td>",
"       <td>",
"        140",
"       </td>",
"       <td>",
"        75-160",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 years to 10 years",
"       </td>",
"       <td>",
"        60-140",
"       </td>",
"       <td>",
"        80",
"       </td>",
"       <td>",
"        60-90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;10 years",
"       </td>",
"       <td>",
"        60-100",
"       </td>",
"       <td>",
"        75",
"       </td>",
"       <td>",
"        50-90",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Gillette, PC, Garson, A Jr, Porter, CJ, McNamara, DG. Dysrhythmias. In: Adams, FH, Emmanouilides, GC, Riemenschneider, TA (Eds), Moss' heart disease in infants, children and adolescents, 4th ed, Williams &amp;Wilkin, Baltimore 1989.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17947=[""].join("\n");
var outline_f17_33_17947=null;
var title_f17_33_17948="Severity of AS in adults";
var content_f17_33_17948=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65280&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65280&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Severity of aortic stenosis in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"10%\">",
"     </colgroup>",
"     <colgroup span=\"3\" width=\"30%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Aortic jet velocity",
"        <br/>",
"        (m/sec)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mean gradient",
"        <br/>",
"        (mmHg)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Valve area",
"        <br/>",
"        (cm",
"        <sup>",
"         2",
"        </sup>",
"        )",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Normal",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        &le;2.0",
"       </td>",
"       <td class=\"centered\">",
"        &lt;5",
"       </td>",
"       <td class=\"centered\">",
"        3.0 to 4.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Mild",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        &lt;3.0",
"       </td>",
"       <td class=\"centered\">",
"        &lt;25",
"       </td>",
"       <td class=\"centered\">",
"        &gt;1.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Moderate",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        3.0 to 4.0",
"       </td>",
"       <td class=\"centered\">",
"        25 to 40",
"       </td>",
"       <td class=\"centered\">",
"        1.0 to 1.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Severe",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        &gt;4.0",
"       </td>",
"       <td class=\"centered\">",
"        &gt;40",
"       </td>",
"       <td class=\"centered\">",
"        &lt;1.0*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Critical aortic stenosis has been defined hemodynamically as a valve area &lt;0.75 cm",
"    <sup>",
"     2",
"    </sup>",
"    and/or an aortic jet velocity &gt;5.0 m/sec. However, the decision about valve replacement is not based solely on hemodynamics, as some patients who meet these criteria are asymptomatic, while others with less severe measurements are symptomatic. In patients with severe aortic stenosis who also have a low cardiac output state, the aortic jet velocity and mean gradient may be lower than indicated above (low-gradient aortic stenosis).",
"    <div class=\"footnotes\">",
"     * Severe aortic stenosis is also considered to be present if the valve area indexed by body surface area is &lt;0.6 cm",
"     <sup>",
"      2",
"     </sup>",
"     /m",
"     <sup>",
"      2",
"     </sup>",
"     .",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17948=[""].join("\n");
var outline_f17_33_17948=null;
var title_f17_33_17949="Tympanograms in diseases";
var content_f17_33_17949=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73425&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 491px\">",
"   <div class=\"ttl\">",
"    Tympanograms in various diseases",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 471px; height: 342px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Type A: Normal tympanic membrane (TM) mobility. Type B: Flat tympanogram associated with fluid or perforation (will have large volume). Type C: Negative middle ear pressure such as from a retracted TM. Type AS: Very stiff noncompliant TM associated with TM sclerosis or otosclerosis. Type AD: Hypermobile usually associated with ossicular discontinuity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17949=[""].join("\n");
var outline_f17_33_17949=null;
var title_f17_33_17950="Diseases assoc with cryos I";
var content_f17_33_17950=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F77121%7ERHEUM%2F52034&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F77121%7ERHEUM%2F52034&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Types of cryoglobulinemia and their clinical associations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Essential",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Familial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C4 deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C3 deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Factor XIII deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Viral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Adenovirus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hantavirus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatitis viruses: A, B, C",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Herpes viruses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Epstein-Barr",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Varicella-Zoster",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Human T cell leukemia virus (HTLV)-I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Human immunodeficiency virus (HIV)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Influenza virus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Parvovirus B19",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rubella virus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Bacterial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Brucella",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Infective endocarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Postintestinal bypass arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Leprosy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lyme disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rickettsia, including coxiella brunetii (Q fever)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Poststreptococcal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Syphilis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Fungal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Coccidiomycosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Parasitic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Echinococcosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Leishmaniasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malaria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Schistosomiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Toxoplasmosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tropical splenomegaly syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trypanasomiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Autoimmune",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Connective tissue diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Drug-induced lupus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Polymyositis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rheumatoid arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sj&ouml;gren's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Systemic sclerosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Systemic vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Beh&ccedil;et's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Henoch-Sch&ouml;nlein purpura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Kawasaki disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Polyarteritis nodosa (+/- hepatitis B)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dispenzieri, A, Gorevic, PD. Cryoglobulinemia. Hematology-Oncology Clinics of North America 1999; 42:2507. Copyright &copy; 1999 W.B. Saunders Company.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Types of cryoglobulinemia and their clinical associations (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Autoimmune (continued)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Dermatological disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cold-induced urticaria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cutaneous vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Epidermolysis bullosa acquisita",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Erythema elevatum diutinum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Erythema multiforme",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pemphigus vulgaris",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pyoderma gangrenosum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Inflammatory bowel disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Celiac disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Crohn's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ulcerative colitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Paraneoplastic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atrial myxoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lung cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Lymphoproliferative disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Leukemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Chronic lymphocytic leukemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Chronic meylocytic leukemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Hairy cell leukemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lymphoma: Hodgkin's and non-Hodgkin's",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Plasma cell disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Dysproteinemias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Macroglobulinemia, primary or secondary (eg, Waldenstr&ouml;m's)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Multiple myeloma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        POEMS syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Angioimmunoblastic lymphadenopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kaposi's sarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycosis fungoides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nasopharyngeal carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Renal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic membranoproliferative glomerulonephritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Iatrogenic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bacille Calmette-Guerin administration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Influenza vaccine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumococcal vaccine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Miscellaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Cirrhosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Biliary, La&euml;nnec's, postnecrotic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Endomyocardial fibrosis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dispenzieri, A, Gorevic, PD. Cryoglobulinemia. Hematology-Oncology Clinics of North America 1999; 42:2507. Copyright &copy; 1999 W.B. Saunders Company.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17950=[""].join("\n");
var outline_f17_33_17950=null;
var title_f17_33_17951="Diagnosis neutrocytic ascites";
var content_f17_33_17951=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diagnostic approach to the patient with neutrocytic ascites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 650px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Akrivladis EA, Runyon BA. Gastroenterology 1990; 98:127.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_33_17951=[""].join("\n");
var outline_f17_33_17951=null;
